The QualityStocks Daily Wednesday, May 8th, 2024

Today's Top 3 Investment Newsletters

MarketClub Analysis(REBN) $3.1900 +84.39%

Schaeffer's(INOD) $10.4700 +55.34%

FreeRealTime(ELAN) $16.8900 +24.93%

The QualityStocks Daily Stock List

KYN Capital Group (KYNC)

QualityStocks, Shiznit Stocks and Penny Stock General reported earlier on KYN Capital Group (KYNC), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

KYN Capital Group, Inc. (OTC: KYNC) is a holding firm that is focused on equipment leasing, asset-based lending and real estate acquisitions.

The firm has its headquarters in Ione, California and was incorporated in September 1997, by Jing Min Chen. Prior to its name change in April 2015, the firm was known as New Taohuayuan Culture Tourism Co. Ltd. It serves consumers around the globe.

The company operates through the equipment leasing, asset-based lending, real estate acquisitions, and real estate investment segments. The equipment leasing segment consists of leases for trucks, cars, submarines, yacht and shop, mining equipment, airplanes and other equipment. The asset-based lending segment is engaged in the provision of real estate synthetic leases where it purchases an asset for a client and leases it to them. The real estate acquisitions segment purchases real estate under market value, with the equity available being re-invested as capital. On the other hand, the real estate investment segment offers asset-based loans for individuals and companies that offer suitable and sufficient collateral for loans.

The enterprise, which also dabbles in touchless payments, cryptocurrency and blockchain, provides a contactless crypto payment gateway for businesses, known as Koinfoldpay. This gateway enables businesses to received Litecoin, Bitcoin cash, Ethereum and Bitcoin for online payments.

The firm is set to release various products, including a super app which integrates a Home Services Marketplace and the Koinfold Crypto Exchange. These verticals offer the firm several new revenue streams and make it the first firm to package such technologies into a streamlined user experience. This move will not only bring additional revenue into the firm but may also extend the firm’s consumer reach.

KYN Capital Group (KYNC), closed Wednesday's trading session at $0.0008, up 45.4545%, on 158,770,700 volume. The average volume for the last 3 months is 18,475 and the stock's 52-week low/high is $0.0002/$0.0014.

Oxbridge Re Holdings (OXBR)

TradersPro, The Online Investor, MarketBeat, StockMarketWatch, Fierce Analyst, StockWireNews, Small Cap Firm, PennyStockScholar, PennyStockProphet, Profitable Trader Authority, QualityStocks, StreetInsider, OTCtipReporter, BUYINS.NET, MarketClub Analysis, Marketbeat.com, InvestorPlace and InsiderTrades reported earlier on Oxbridge Re Holdings (OXBR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Oxbridge Re Holdings Ltd. (NASDAQ: OXBR) is engaged in the provision of casualty and special property reinsurance solutions to casualty and property insurers in the Gulf Coast area in the U.S.

The firm has its headquarters in George Town in the Cayman Islands and was founded in 2013, on April 4th. It operates as part of the financial sector, under the insurance industry.

The company’s objective is to achieve long-term growth in book value per share by writing businesses that will generate huge profits relative to the risk the company bears.

The enterprise specializes in underwriting high severity and medium frequency risks as it believes that there’s adequate data to effectively analyze the return/risk profile of reinsurance contracts. It writes fully collateralized policies that cover property losses from certain catastrophes through Oxbridge Reinsurance Ltd, its wholly owned subsidiary which has been approved by the Cayman Islands Monetary Authority as a licensed insurance firm, as per the law in the Cayman Islands. It also provides its services through its Oxbridge RE NS subsidiary.

The firm’s first quarter results for 2021 show that no losses were incurred during this quarter, with the results also demonstrating that the company’s income also increased. Positive change in the fair value of equity securities also helped improve the firm’s results. The firm’s CEO noted that the company was focused on evaluating new growth opportunities and was looking forward to their long-term prospects, while mitigating risk.

Oxbridge Re Holdings (OXBR), closed Wednesday's trading session at $1.54, up 21.2598%, on 303,538 volume. The average volume for the last 3 months is 224,972 and the stock's 52-week low/high is $0.87/$2.03.

Imunon Inc. (IMNN)

We reported earlier on Imunon Inc. (IMNN), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Imunon Inc. (NASDAQ: IMNN) (FRA: CBO) (LON: 0HUZ) is a clinical-stage biopharmaceutical firm that is focused on developing and commercializing DNA-based vaccines, immunotherapies and directed chemotherapies.

The firm has its headquarters in Lawreneceville, New Jersey and was incorporated in 1982 by Yim-Pan Cheung. Prior to its name change, the firm was known as Celsion Corp. It operates as part of the biotechnology industry, under the healthcare sector. The firm serves consumers around the globe.

The company is focused on advancing a portfolio of innovative treatments which harness the body's natural mechanisms to generate effective, safe and durable responses across a broad array of human illnesses. It operates through the ThermoDox and Celsion brands.

The enterprise has developed a feasibility stage platform technology for the development of nucleic acid-based vaccines, immunotherapies and other anti-cancer DNA or RNA therapies dubbed TheraPlas; and its Placcine platform, which develops nucleic acid vaccines for cancer and other infectious illnesses. Its product pipeline is comprised of a DNA-based immunotherapy dubbed GEN-1, which has been developed to locally treat ovarian cancer. It also develops a proprietary heat-activated liposomal encapsulation of doxorubicin known as ThermoDox, which is in the development stage for a range of cancer indications.

The company, which recently provided a business update, remains focused on advancing its pipeline, whose success and approval will bring in additional revenues and investments into the firm. This is in addition to benefiting patients with various indications and generating value for its shareholders.

Imunon Inc. (IMNN), closed Wednesday's trading session at $1.5, up 17.1875%, on 85,856 volume. The average volume for the last 3 months is 19.869M and the stock's 52-week low/high is $0.48/$2.00.

International Star (ILST)

QualityStocks, PennyStocks24, MarketClub Analysis, Pennybuster, OTC Stock Review, Wallstreetlivechat and Stock Traders Chat reported earlier on International Star (ILST), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

International Star Inc. (OTC: ILST) is an exploration-stage firm that is focused on exploring for and acquiring precious and base metal mineral properties.

The firm has its headquarters in Shreveport, Louisiana and was incorporated in 1993, on October 28th. Prior to its name change in 1997, the firm was known as Mattress Showrooms Inc. It operates as part of the metal ore mining industry, under the natural resources sector. The firm serves consumers in the United States.

The company prides itself on being an ecologically responsible mining firm. Its objective is to generate significant investor returns via acquiring and developing undervalued precious metal assets that can generate cash.

The enterprise’s mineral properties include the Black Mountains Property, which covers about 1.8 square miles of land and is situated in the northern Black Mountains in Arizona, over 21 miles south of the Hoover Dam and about 55 miles from Las Vegas. This property is underlain by roughly 3 basic rock units and is made up of about 10 lode claims. It also has a Van Deemen Gold mine site, which contains roughly 34,000 ounces of gold. The mine site’s resource/ reserve base is being expanded. Its other properties include unpatented mining claims situated on federal public land managed by the Bureau of Land Management, under the U.S. Department of Interior. The enterprise’s primary products are silver, gold and other materials extracted from ore bodies.

The company is focused on generating investor returns through acquiring and developing base metal and precious mineral properties.

International Star (ILST), closed Wednesday's trading session at $0.0023, up 15%, on 61,548,704 volume. The average volume for the last 3 months is 164,700 and the stock's 52-week low/high is $0.0003/$0.0028.

RumbleON (RMBL)

MarketBeat, QualityStocks, InsiderTrades, TradersPro, StreetInsider, MarketClub Analysis, Trading Concepts, StocksEarning, StockMarketWatch, Schaeffer's, Early Bird and BUYINS.NET reported earlier on RumbleON (RMBL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

RumbleON Inc. (NASDAQ: RMBL) (FRA: 4QO1) is a technology-based omnichannel platform that is engaged in the provision of internet based services.

The firm has its headquarters in Irving, Texas and was incorporated in 2013, on October 24th by Steven Richard Berrard, Marshall Chesrown and Matthew A. Lane. Prior to its name change in February 2017, the firm was known as Smart Server Inc. It operates as part of the auto and truck dealerships industry, under the consumer cyclical sector. The firm mainly serves consumers in the United States.

The company operates through the Powersports, Vehicle Logistics and Transportation, and Automotive segments. The Powersports segment distributes motorcycles and other powersports vehicles while the Vehicle Logistics and Transportation segment offers nationwide transportation brokerage services between dealerships and auctions. On the other hand, the Automotive segment distributes cars and trucks. The company generates most of its revenue from the Powersports segment.

The enterprise’s platform offers the ability to buy, sell, trade, and finance new and pre-owned vehicles online or in store for dealers and consumers. Its offerings include personal watercraft, motorcycles, all-terrain vehicles, utility terrain vehicles and all other powersports products, parts, apparel, and accessories. It has approximately 55 retail locations and over 60 websites to shop for powersports products, as well as for parts, accessories and merchandise.

The firm, which recently announced its latest financial results, remains committed to making progress on its transformation plan as it works to meet its short and long-term goals and enhancing value for its shareholders. This may positively influence the firm’s overall growth.

RumbleON (RMBL), closed Wednesday's trading session at $5.45, up 11.4519%, on 194,007 volume. The average volume for the last 3 months is 669,036 and the stock's 52-week low/high is $4.82/$13.52.

Achilles Therapeutics (ACHL)

We reported earlier on Achilles Therapeutics (ACHL), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Achilles Therapeutics Plc (NASDAQ: ACHL) (FRA: 698) is a clinical stage immune-oncology biopharmaceutical firm that is engaged in the development of precision T cell therapies for the treatment of different types of solid tumors.

The firm has its headquarters in London, the United Kingdom and was incorporated in 2016. It operates as part of the scientific research and development services industry, under the healthcare sector. The firm has three companies in its corporate family and serves consumers in the United Kingdom.

The company uses a proprietary bioinformatics platform and DNA sequencing data from patients to identify clonal neoantigens specific to a particular patient. This allows the development of personalized cell therapies which target and destroy tumors without causing damage to healthy tissues.

The enterprise’s product pipeline comprises of a formulation dubbed Thetis, which is undergoing a phase 2a clinical trial evaluating its effectiveness in treating recurrent or metastatic melanoma; and a formulation known as Chiron, which is in a phase 1 clinical trial testing its efficacy in treating advanced non-small cell lung cancer. The enterprise is also involved in the development of products used to treat bladder cancer, triple negative breast cancer, renal cell carcinoma, as well as neck and head squamous cell carcinoma.

The company recently entered into a research and license agreement with Secarna Pharmaceuticals, which is focused on addressing unmet medical needs in immunology and immune-oncology. This move may break new ground in the treatment of various cancers and bring in more investments into both companies, which will be good for their growth.

Achilles Therapeutics (ACHL), closed Wednesday's trading session at $0.9189, up 11.247%, on 572,722 volume. The average volume for the last 3 months is 283,824 and the stock's 52-week low/high is $0.74/$1.76.

Corbus Pharmaceuticals Holdings (CRBP)

MarketBeat, MarketClub Analysis, Wall Street Resources, Schaeffer's, QualityStocks, StockOodles, InvestorPlace, The Street, BUYINS.NET, StockMarketWatch, Wealth Insider Alert, Marketbeat.com, Promotion Stock Secrets, TradersPro, INO Market Report, StreetInsider, InsiderTrades, Barchart, Kiplinger Today, Profit Confidential, Street Insider, TraderPower, The Stock Dork, Investopedia, Wealth Daily, Market Intelligence Center Alert, Daily Trade Alert, Insider Wealth Alert, Trades Of The Day, AllPennyStocks, Shah's Insights & Indictments, Stock Gumshoe, Stock Market Watch, TopPennyStockMovers, TopStockAnalysts and Money Wealth Matters reported earlier on Corbus Pharmaceuticals Holdings (CRBP), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ: CRBP) (FRA: 337) is a pharmaceutical firm which develops and markets various therapeutics to treat severe, chronic and rare fibrotic and inflammatory ailments.

Corbus Pharmaceuticals is based in Norwood, Massachusetts and was founded in 2009. The firm is part of the pharmaceutical manufacturing industry and offers its services in Australia, Europe, Israel and the United States. The Corbus Pharmaceuticals corporate family has 3 firms under it.

Corbus Pharmaceuticals Holdings has a collaboration with Kaken Pharmaceutical Co. Ltd to develop and market lenabasum in Japan and a licensing agreement with Jenrin Discovery for the development and commercialization of licensed products, including the company’s library of roughly 600 compounds and multiple pending and issued patent filings.

The firm’s lead product candidate, lenabasum is an oral endocannabinoid drug which has been designed to treat fibrotic and chronic inflammation processes. The synthetic drug candidate is currently in its phase 2b clinical trial to test for its effectiveness in treating cystic fibrosis and systemic lupus erythematosus as well as undergoing its phase 3 clinical trial for the treatment of skin-predominant diffuse cutaneous dermatomyositis and systemic sclerosis. Additionally, the firm is developing CRB-4001, a CB1 inverse agonist, for fibrotic diseases like nonalcoholic steatohepatitis.

The firm’s lenabasum candidate would be very beneficial to individuals suffering from inflammatory or fibrotic ailments, who need effective treatments. While the drug is yet to be approved for treatment, positive results from its clinical trials show that its well on its way.

Corbus Pharmaceuticals Holdings (CRBP), closed Wednesday's trading session at $42.39, up 6.5879%, on 779,421 volume. The average volume for the last 3 months is 2,685 and the stock's 52-week low/high is $3.0334/$49.8699.

Gyrodyne (GYRO)

Louis Navellier, StreetInsider, Street Insider, Marketbeat.com, MarketBeat and FeedBlitz reported earlier on Gyrodyne (GYRO), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Gyrodyne LLC (NASDAQ: GYRO) is a limited liability firm focused on owning and managing a diversified portfolio of real estate properties comprising of industrial, service and office-oriented properties in the New York metropolitan area.

The firm has its headquarters in St. James, New York and was incorporated in 1946 by Peter James Papadakos. It operates as part of the real estate services industry, under the real estate sector. The firm mainly serves consumers in the United States.

The company’s primary business is the management of a portfolio of medical office and industrial properties and the pursuit of entitlements on such properties located in Westchester (Cortlandt Manor) and Suffolk (Flowerfield) counties, New York. Flowerfield is its flagship property, located on the north shore of Long Island in the hamlet of St. James. The 68-acre tract, primarily zoned for light industry, includes about 130,000 rentable square feet located on almost 10 acres of developed property at Flowerfield, with the balance proposed for the development of an age-restricted residential community. The company also owns a 63-acre site about 50 miles east of New York City on the north shore of Long Island, which includes industrial and office buildings and undeveloped property, and a medical office park in Cortlandt Manor, New York. In Cortlandt Manor, New York, it owns roughly 13.8 acres inclusive of the 31,421 ft2 Cortlandt Medical Center. In Smithtown, New York, the company owns a light industrial campus that is the subject of its subdivision application with the Town of Smithtown.

The firm, which is party to an agreement with Star Equity Fund LP, remains committed to generating value for its shareholders.

Gyrodyne (GYRO), closed Wednesday's trading session at $7.9, even for the day, on 2 volume. The average volume for the last 3 months is 357,704 and the stock's 52-week low/high is $7.7897/$12.6647.

DeFi Technologies (DEFTF)

RedChip, QualityStocks and InvestorPlace reported earlier on DeFi Technologies (DEFTF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

DeFi Technologies (CBOE CA: DEFI) (GR: R9B) (OTCQB: DEFTF), a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance (“DeFi”), has announced that its subsidiary Valour Inc., a leading issuer of exchange traded products (“ETPs”) that provide simplified access to digital assets, has successfully repaid US$19.5 million in outstanding loans. According to the announcement, as of April 30, 2024, Valour has fully repaid balances of US$6 million and US$13.5 million, which were secured by BTC and ETH collateral, respectively. No further equity or debt was raised to repay the loans.

To view the full press release, visit https://ibn.fm/4jnCk

About DeFi Technologies Inc.

DeFi Technologies is a financial technology company that pioneers the convergence of traditional capital markets with the world of decentralized finance (“DeFi”). With a dedicated focus on industry leading Web3 technologies, the company aims to provide widespread investor access to the future of finance. Backed by an esteemed team of experts with extensive experience in financial markets and digital assets, DeFi Technologies is committed to revolutionizing the way individuals and institutions interact with the evolving financial ecosystem. Join DeFi Technologies’ digital community on Linkedin and Twitter and, for more details, visit https://defi.tech/.

DeFi Technologies (DEFTF), closed Wednesday's trading session at $0.5669, off by 3.1271%, on 501,437 volume. The average volume for the last 3 months is 894,360 and the stock's 52-week low/high is $0.0485/$0.726.

Cresco Labs Inc. (CRLBF)

QualityStocks, InvestorPlace, Kiplinger Today, Daily Trade Alert, MarketBeat, Cabot Wealth, Top Pros' Top Picks, The Street, The Wealth Report, Wealth Insider Alert, Trading For Keeps, Trades Of The Day, The Online Investor, CannabisNewsWire, Early Bird, Prism MarketView, StreetInsider, wyatt research newsletter, TradersPro and StocksEarning reported earlier on Cresco Labs Inc. (CRLBF), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

U.S. cannabis businesses undergoing distress often face hurdles in seeking bankruptcy protection, a common challenge in an industry prone to business downturns. However, there’s a glimmer of hope on the horizon with potential federal rescheduling of cannabis and shifting perspectives evident in recent bankruptcy cases.

Duane Morris Law firm associate, Ryan Spengler, expressed cautious optimism, noting that advancements in court rulings coupled with potential rescheduling may pave the way for new bankruptcy avenues for U.S. marijuana businesses. He stated that even before federal rescheduling, if bankruptcy courts begin to show leniency towards marijuana-related companies, it could signal a positive trend for the industry.

Meanwhile, distressed marijuana enterprises are exploring out-of-court restructuring and state court receiverships as alternatives to filing for federal bankruptcy. Some are even turning to Canadian insolvency rules, where applicable.

Federal bankruptcy laws in the United States mandate that bankruptcy plans must be proposed in good faith and in compliance with all applicable regulations. Since cannabis remains illegal under federal law, even state-regulated cannabis companies are excluded from federal bankruptcy protections.

Although rescheduling marijuana might seem like a solution, Spengler points out that it wouldn’t address the federal barrier to bankruptcy. He explains that regardless of whether marijuana is classified as Schedule I or III, bankruptcy courts would still view it as a federal violation.

New court rulings, nevertheless, provide some hope. A possible change in perspective is indicated by the fact that certain courts have started to permit the division of assets connected to cannabis for the advantage of debtors and creditors.

For instance, a 2023 ruling by a California bankruptcy court set a precedent by allowing the sale of stock in a Canadian marijuana company as part of a bankruptcy plan. Similarly, another case in 2023 saw approval from a bankruptcy court indicating the potential for more innovative approaches in marijuana bankruptcy cases.

Rescheduling marijuana could present fresh prospects for bankrupt cannabis companies, according to Kevin McLaughlin, a partner at Centri Business Consulting. He anticipates that eliminating 280E taxation, which is associated with Schedule III classification, could make cannabis businesses more attractive for restructuring. Despite the limitations in bankruptcy options, McLaughlin notes that cannabis companies still have alternatives such as out-of-court restructuring and receivership.

In the meantime, as regulated cannabis companies await changes in bankruptcy laws, income derived from the marijuana industry also poses challenges in personal bankruptcy cases.

Recent court decisions indicate a gradual shift away from a strict stance against marijuana-involved debtors seeking bankruptcy relief. This shift offers a glimmer of hope for individuals working in the industry who may seek bankruptcy protection in the future.

Any positive reforms to the existing federal marijuana policies are likely to be a welcome development to industry actors such as Cresco Labs Inc. (CSE: CL) (OTCQX: CRLBF) given how much the current prohibitionist environment has hamstrung their operations and growth.

Cresco Labs Inc. (CRLBF), closed Wednesday's trading session at $2.055, up 2.75%, on 580,430 volume. The average volume for the last 3 months is 149,457 and the stock's 52-week low/high is $1.00/$2.77.

Bit Mining Ltd. (BTCM)

QualityStocks, MarketClub Analysis, StockEarnings, Schaeffer's, CryptoCurrencyWire, Wall St. Warrior, The Stock Dork, StocksEarning, smartmoneytrading, MarketBeat, INO Market Report, FreeRealTime and 247 Market News reported earlier on Bit Mining Ltd. (BTCM), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Bitcoin maintained its position above the $60,000 mark after the release of the U.S. job market report on April 3, 2024. The new report altered predictions about when the Fed would cut its key interest rate, moving it to September instead of November.

Following the report’s publication, Bitcoin saw a rise of more than 4%, continuing its upward trend toward $62,000, as per data from CoinMarketCap. Bitcoin has seen substantial buying activity in recent hours, sending it above the $60K level. It did, however, run into some opposition at the $62K mark. At the moment, the price of Bitcoin is $61,783, up more than 4.6% over the previous day.

Ether also saw a rebound, crossing the $3,000 mark once again after fluctuating in the high $2,000 range for most of the week.

According to Ki Young Ju, CEO of CryptoQuant, Bitcoin whales amassed 47,000 BTC ahead of the Fed’s report.

The release of macroeconomic data has led to a revision in expectations regarding the Fed’s key interest-rate trajectory for 2024. Instead of one cut, the market is now factoring in two 0.25% cuts, with the first anticipated in September instead of November, prior to the statistical release.

Bloomberg analysts stressed that investors will need to pay close attention to the consumer pricing dynamics report, which is scheduled for release on May 15, 2024.

Ali Jaffery, an expert from CIBC Capital Markets, noted that despite the overall strength of the job market, further evidence of a slowdown or an unexpected sharp decline in employment is needed for the Federal Open Market Committee (FOMC) to reassess its employment mandate. Ultimately, the FOMC will maintain its current stance until there is clarity on inflation.

Following the publication of the job market report, global markets became more risk averse. The S&P 500’s stock index increased by 1.2%, but the fear and greed index for cryptocurrencies increased by five points, moving from fear to neutrality.

Recently, Bitcoin dropped below the $60,000 mark. Analysts at Santiment observed that the release of U.S. data generated conversations centered on the hashtag #buythedip and references to Bitcoin. This increase in sentiment suggests that traders are once again divided; some view it as a chance to purchase while others are cautious.

A number of factors, including Block’s declaration that it intended to buy Bitcoin, contributed to the cryptocurrency’s recent upswing. Block disclosed plans in its most recent earnings report to devote 10% of its gross sales from BTC goods to monthly BTC purchases, which might increase the present buying fervor.

As BTC continues its upward climb, industry actors such as Bit Mining Ltd. (NYSE: BTCM) are likely to enjoy some of the benefits that come from this bullish market, such as growth in investor interest as more people look to leverage the surging prices of cryptos.

Bit Mining Ltd. (BTCM), closed Wednesday's trading session at $2.61, off by 1.1364%, on 34,177 volume. The average volume for the last 3 months is 57.025M and the stock's 52-week low/high is $1.79/$6.95.

Palantir Technologies Inc. (PLTR)

Kiplinger Today, InvestorPlace, Schaeffer's, MarketClub Analysis, INO Market Report, StockEarnings, MarketBeat, The Street, Early Bird, StocksEarning, Zacks, Trades Of The Day, Daily Trade Alert, The Online Investor, Top Pros' Top Picks, InvestorsUnderground, StreetInsider, Cabot Wealth, The Night Owl, The Wealth Report, Investopedia, CNBC Breaking News, FreeRealTime, Investment House, Earnings360, QualityStocks, Smartmoneytrading, TradersPro, Smart Investing Society, DividendStocks, Prism MarketView, bullseyeoptiontrading, AllPennyStocks, InsiderTrades, Lance Ippolito, 360wallstreet, OTC Stock Review, Rick Saddler, The Stock Dork, Tim Bohen, Uptick Daily, Wealth Insider Alert, wyatt research newsletter and Money Morning reported earlier on Palantir Technologies Inc. (PLTR), and today we highlight the Company, here at the QualityStocks Daily Newsletter.

Artificial intelligence is one of the most significant advancements in military aviation since stealth was introduced in the 1990s. The Air Force’s interest and involvement in this field has grown these last few years.

While the current tech isn’t fully developed, the Air Force plans to build an artificial intelligence (AI)-enabled fleet of more than 1,000 unmanned warplanes, the first of which shall commence operations in 2028. AI agents are already being trained to fly in war at Edwards Air Force Base, a facility located in the desert. It was here that Chuck Yeager broke the speed of sound.

Frank Kendall, an Air Force secretary, recently had the privilege of flying a jet using artificial intelligence. Seated in the front seat of the experimental F-16 fighter jet dubbed Vista, Kendall flew at more than 550 miles per hour, putting pressure five times the force of gravity on his body.

Following the hour-long flight, Kendall in his capacity as an air force secretary made a public statement of confidence on the future role of AI in air combat. He noted that not having it was a security risk, then admitted that he would trust this tech with the ability to make decisions on whether or not to deploy weapons in war.

Not all are in favor of the military using artificial intelligence. Humanitarian groups and arms-control experts have raised concerns that one day AI may develop the ability to autonomously deploy bombs that kill individuals without needing to consult humans.

In its warning, the International Committee of the Red Cross noted that there were serious and widespread concerns about relinquishing life-and-death decisions to software and sensors. It added that autonomous weapons demanded an urgent, global political response and were an immediate cause of concern.

The shift to artificial intelligence-enabled planes by the military is being driven by strategic capability, cost and security. Vista operators hold the opinion that no other nation globally has a jet like its own. The tech’s uniqueness comes from the fact that the software processes data in a simulator then examines its conclusions in actual fights. Data from the actual fights is then fed back into the simulator, and the AI processes it to better understand combat.

Thus far, the reports show that some versions of this tech, as tested on the fighter jets, is already besting human pilots in air-to-air combat. This doesn’t unnerve pilots at the base, however, who may be training their replacements.

As companies such as Palantir Technologies Inc. (NYSE: PLTR) continue making advances in the development of AI software, these technologies are likely to make their presence and utility felt in different industries, not only in defense.

Palantir Technologies Inc. (PLTR), closed Wednesday's trading session at $21.56, up 0.7476636%, on 67,582,882 volume. The average volume for the last 3 months is 3,534 and the stock's 52-week low/high is $7.59/$27.50.

The QualityStocks Company Corner

Astrotech Corp. (NASDAQ: ASTC)

The QualityStocks Daily Newsletter would like to spotlight Astrotech Corp. (NASDAQ: ASTC).

Steps to change marijuana's classification at the federal level in America have been initiated by both Congress and the Biden Administration in the last year. On his part, President Joseph Biden directed that a review of federal cannabis law be conducted, and he pardoned thousands who had been federally convicted of simple possession of cannabis. Currently, marijuana is classified under Schedule I of the Controlled Substances Act. Substances under this classification are said to have no accepted medical use and high abuse potential. Other drugs under this classification include LSD, heroin, MDMA, methaqualone and mescaline (peyote). In a recent press conference, Schumer revealed that the measure would expunge criminal records of individuals with low-level cannabis offenses, which prevent them from getting ahead in life. The changing regulatory landscape at the federal level is likely to create market opportunities for entities such as Astrotech Corp. (NASDAQ: ASTC) if they position themselves appropriately to leverage the evolving market conditions.

Astrotech Corp. (NASDAQ: ASTC) is an instrumentation company that designs, manufactures and commercializes solutions. Its solutions include mass spectrometry, process controls, chemical detectors and medical disease detection.

The company was established in 1984 and, prior to 2009, was known as SPACEHAB Inc., a NASA contractor offering technology originally developed for NASA to monitor air quality on the International Space Station. When the Space Shuttle program ended, the company focused on its satellite processing and mass spectrometer instrumentation units and adopted the Astrotech name.

In 2014, Astrotech sold its satellite subsidiary to focus on its Astrotech Technology Inc. (ATi) mass spectrometry solutions, which offer a number of advantages over competing platforms. Notably, Astrotech’s ATi technology is ruggedized, rapid, simple to use and customizable, with hands-free calibration and tuning.

Between 2016 and 2019, the company secured U.S. patents for its technology and achieved European Union (ECAC) certification for the TRACER 1000™, the world’s first mass-spec Explosives Trace Detector (ETD) used in airports worldwide. Astrotech continues to innovate and add to its suite of products, including AgLAB-1000, a process control system, and the BreathTest 1000, a disease detection solution.

Astrotech is headquartered in Austin, Texas.

Subsidiaries

Astrotech Technologies Inc.

Astrotech Technologies Inc. (ATi) owns and licenses the platform mass spectrometry technology originally developed by 1st Detect. This technology is designed to be less expensive, smaller and easier to use than traditional mass spectrometers.

Unlike other technologies, ATi works under high vacuum, which eliminates competing molecules, yielding higher resolution and fewer false alarms. The company’s intellectual property includes 18 granted patents, along with extensive trade secrets.

ATi exclusively licenses the Astrotech Mass Spectrometer Technology to the three wholly owned subsidiaries of Astrotech.

1st Detect Corp.

1st Detect Corp. developed the TRACER 1000, the world’s first mass spectrometry-based explosives and narcotics trace detector. 1st Detect ETDs were developed for use at airports, cargo facilities and other secured locations and borders worldwide.

1st Detect’s commercial sales of the TRACER 1000 ETD, consumables and recurring maintenance services brought in $750,000 in total revenue during the fiscal year ended June 30, 2023. The Astrotech subsidiary recently secured two orders for a total of 24 Tracer 1000 units from two Romanian security and telecommunications companies, to be delivered during calendar 2023.

AgLAB Inc.

AgLAB Inc. is developing a series of mass spectrometers for use in the hemp and cannabis market, with an initial focus on optimizing yields in the distillation processes.

AgLAB, which uses the company’s proprietary AgLAB 1000-D2™ mass spectrometer, has been proven to improve distillation oil yields and bottom-line profits for hemp and cannabis producers. During field trials, AgLAB was able to improve ending-weight yields by an average of 24%.

BreathTech Corp.

BreathTech is developing the BreathTest-1000™, a breath analysis tool to screen for volatile organic compound (“VOC”) metabolites found in a person’s breath that could indicate they may have a compromised condition including but not limited to a bacterial or viral infection. The company believes that new tools to aid in the battle against COVID-19 and other diseases remain of the utmost importance to help more quickly identify that an infection may be present.

Market Opportunity

A report by Mordor Intelligence, a research and advisory firm, put the global mass spectrometry market at $6.37 billion in 2023. The market is forecast to grow to $8.63 billion by 2028, achieving a CAGR of 6.25% during the forecast period.

One of the major driving factors for the growth of the mass spectrometry market is technological advancements in mass spectrometer devices, the report states. Key market players are continuously working toward advancing their existing products and launching innovative and advanced mass spectrometer devices.

Another major factor that is expected to boost market growth is increasing research and development expenditure by both government and private entities, according to the report. Mass spectrometry devices are also being used in the detection and analysis of COVID-19 and other disease samples, which may have a positive impact on the market.

Management Team

The Astrotech leadership team includes management executives, as well as industry and technology experts. The company continues to actively expand its talent pool to meet evolving demands.

Thomas B. Pickens III is Chairman, CEO and Chief Technology Officer of Astrotech Corp. He also serves as CEO of Astrotech subsidiaries ATi, 1st Detect, AgLAB Inc. and BreathTech Corp. Previously, he was the founder and president of Beta Computer Systems Inc. and T.B. Pickens & Co. He was founder and general partner of Grace Pickens Acquisition Partners L.P and managing partner of Sumpter Partners. He also served as CEO of Catalyst Energy Corporation and United Thermal Corporation and as president of Golden Bear Corp., United Hydro Inc. and Slate Creek Corp. He received a B.A. in Economics, Computer Science and Engineering from Southern Methodist University.

Jaime Hinojosa, CPA, is CFO at Astrotech Corp. He joined the company in 2015 and has served as its Corporate Controller since 2019. His previous roles with the company include Director of Finance, from 2017 to 2019, and Assistant Controller, from 2015 to 2017. Prior to joining Astrotech, Mr. Hinojosa worked as an Accounting Manager for O’Reilly Auto Parts and gained public accounting experience as an Audit Manager at Burton McCumber & Cortez LLP.

Astrotech Corp. (NASDAQ: ASTC), closed Wednesday's trading session at $9.7, up 3.0818%, on 1,052 volume. The average volume for the last 3 months is 493,842 and the stock's 52-week low/high is $7.00/$15.11.

Recent News

Lexaria Bioscience Corp. (NASDAQ: LEXX)

The QualityStocks Daily Newsletter would like to spotlight Lexaria Bioscience Corp. (NASDAQ: LEXX).

Lexaria Bioscience (NASDAQ: LEXX, LEXXW), a global innovator in drug delivery platforms, today announced that its second human pilot study, GLP-1-H24-2, is underway and the first dosing visit for all nine study participants has concluded. The three-arm, crossover study will compare three 7 mg semaglutide dose formulations: A positive control Rybelsus(R) swallowed tablet (already dosed); DehydraTECH-semaglutide swallowed capsules; and, for the first time ever, an in-mouth dissolvable DehydraTECH-semaglutide oral tablet. According to the announcement, the second DehydraTECH study arm will use a Rybelsus(R) composition processed with DehydraTECH that is compliant with the U.S. Food and Drug Administration's Inactive Ingredient Database ("FDA IID"), delivered within swallowed capsules. The dosing interval is currently anticipated to complete during mid-June, after the necessary wash-out period for the participants from the first study arm.

To view the full press release, visit https://ibn.fm/zdb5w

Lexaria Bioscience Corp. (NASDAQ: LEXX) is a global innovator in drug delivery platforms. The company’s patented technology, DehydraTECH™, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting healthier oral ingestion methods and increasing the effectiveness of fat-soluble active molecules. DehydraTECH promotes fast-acting, less expensive and more effective oral drug delivery and has been thoroughly evaluated through in vivo, in vitro and human clinical testing.

DehydraTECH is covered by 21 issued and more than 50 pending patents in over 40 countries around the world. Lexaria’s first patent was issued by the U.S. Patent and Trademark Office in October 2016 (US 9,474,725 B1), providing 20 years of patent protection expiring June 2034. Multiple patents have been awarded since then and are expected in the future.

Lexaria has also collaborated with the National Research Council (NRC), the Canadian government’s premier research and technology organization. The company has been granted patent protection for specific delivery of nicotine, vitamins, NSAIDs, antiviral drugs, cannabinoids and more.

Lexaria began developing DehydraTECH in 2014 and has since continued to strengthen and broaden the technology. The company has no plans to create or sell Lexaria-branded products containing controlled substances. Instead, Lexaria licenses its technology to other companies around the world to offer consumers the best possible performance across an array of ingestible product formats.

The company’s technology is best thought of as an additional layer that providers of consumer supplements, prescription and non-prescription drugs, nicotine and CBD products can utilize to improve the effectiveness of their own existing or planned new offerings. Lexaria has licensed DehydraTECH to multiple companies, including a world-leading tobacco producer for the research and development of smokeless, oral-based nicotine products, and for use in industries that produce cannabinoid beverages, edibles and oral products.

DehydraTECH is suitable for use with a wide range of product formats including pharmaceuticals, nutraceuticals, consumer packaged goods and over-the-counter capsules, pills, tablets and oral suspensions.

DehydraTECH Technology

Lexaria’s DehydraTECH is designed specifically for formulating and delivering lipophilic (fat-soluble) drugs and active ingredients. DehydraTECH increases their effectiveness and improves the way active pharmaceutical ingredients enter the bloodstream. The major benefits to a subject ingesting a DehydraTECH-enabled drug or consumer product can be summarized by the following:

  • Speeds up delivery – the effects of the product are felt by the subject in just minutes.
  • Increases bioavailability – the technology is much more effective at delivering a drug or product into the bloodstream.
  • Increases brain absorption – animal testing suggests significant improvement in the quantity of drug delivered across the blood-brain barrier.
  • Improves drug potency – more of the ingested product is made available to the body, so lower doses are required to achieve the desired effect.
  • Reduces drug administration cost – lower doses mean lower overall drug costs.
  • Masks unwanted taste – the technology eliminates or reduces the need for sweeteners.

Lexaria has demonstrated in animal studies a propensity for DehydraTECH technology to elevate the quantity of drug delivered across the blood-brain barrier by as much as 1,900 percent, initiating additional new patent applications and opening possibilities for improved drug delivery.

Since 2016, DehydraTECH has repeatedly demonstrated, with cannabinoids and nicotine, the ability to increase bio-absorption by up to five to 10 times, reduce time of onset from one to two hours to just minutes, and mask unwanted tastes. The technology is to be further evaluated for additional orally administered bioactive molecules, including antivirals, cannabinoids, vitamins, non-steroidal anti-inflammatory drugs (NSAIDs) and nicotine.

Market Outlook

Lexaria’s ongoing research and development efforts are mainly focused on development of product candidates across several key segments:

  • Oral Cannabinoids – a market estimated to be worth $18.4 billion in 2021 and expected to reach $46.2 billion by 2025.
  • Antivirals – an estimated $52.1 billion market in 2021 that’s expected to grow to $66.7 billion by 2025.
  • Oral Mucosal Nicotine – smokeless tobacco products, a $13.6 billion market in 2018, is forecast to grow at 7.2 percent annually through 2025.
  • Human Hormones – estrogen and testosterone replacement therapies represented a $21.9 billion market in 2019, with a forecast CAGR of 7.7 percent through 2027.
  • Ibuprofen and Naproxen – NSAID sales totaled $15.6 billion globally in 2019 and are projected to reach $24.4 billion by 2027.
  • Vitamin D3 – the global market size was $1.1 billion in 2021, growing at 7 percent per year and expected to reach $1.7 billion in 2026.

Management Team

Chris Bunka is Chairman and CEO of Lexaria Bioscience Corp. He is a serial entrepreneur who has been involved in several private and public companies since the late 1980s. He has extensive experience in the capital markets, corporate governance, mergers and acquisitions, as well as corporate finance. He is named as an inventor on multiple patent innovations.

John Docherty, M.Sc., is the President of Lexaria. He is a pharmacologist and toxicologist, and a specialist in the development of drug delivery technologies. He is the former president and COO of Helix BioPharma Corp. (TSX: HBP). He is named as an inventor on multiple issued and pending patents.

Greg Downey is Lexaria’s CFO. He has more than 35 years of diverse financial experience in the mining, oil and gas, manufacturing, and construction industries, and in the public sector. He served for eight years as CFO for several public companies and has provided business advisory and financial accounting services to many large organizations.

Gregg Smith is a strategic advisor to Lexaria. He is a founder and private investor with Evolution VC Partners. He is a member of the Sand Hill Angels and held previous investment banking roles with Cowen and Company and Bank of America Merrill Lynch.

Dr. Philip Ainslie serves as a scientific and medical advisor to Lexaria. He is co-director for the Centre for Heart, Lung and Vascular Health, Canada. He is also Research Chair in Cerebrovascular Physiology and Professor at the School of Health and Exercise Sciences, Faculty of Health and Social Development at the University of British Columbia.

Lexaria Bioscience Corp. (LEXX), closed Wednesday's trading session at $3.54, up 3.207%, on 106,814 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $15.11/$.

Recent News

Zoned Properties Inc. (OTCQB: ZDPY)

The QualityStocks Daily Newsletter would like to spotlightFathom Zoned Properties Inc. (OTCQB: ZDPY).

Cannabis retail dispensaries in Arizona have grown to upwards of 168 locations as of January 2024

Nonetheless, only 1% of Arizona's commercial properties are eligible for use by the cannabis industry

Zoned Properties has been a key partner for the industry in helping cannabis companies establish a physical retail presence

The company has recently announced the approval of a $1 million share buyback plan

The legalized sale of recreational cannabis in Arizona has grown from strength to strength. Possession and cultivation of cannabis across the state became legal on November 30, 2020, with the state-licensed sale of recreational cannabis commencing on January 22, 2021 making Arizona the quickest state in U.S. history to begin retail sales post recreational legalization. Cannabis sales in the state drove over $1.4 billion in revenues in 2023, with the number of dispensaries swelling to 292 as of January 2024 (https://cnw.fm/UyEP2). Nevertheless, further expansion for the industry is easier said than done; at present, only 1 percent of Arizona's commercial real estate properties are applicable to cannabis operators, imposing a further constraint on the growth and development of the state's cannabis retail market. Zoned Properties (OTCQB: ZDPY), a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry in the United States, has been amongst the early leaders in facilitating the transition of the cannabis industry towards the physical retail space. The company maintains a portfolio of six investment properties located across Arizona, Michigan and Illinois; with each of its leased properties occupied by commercial cannabis-linked businesses, the company currently enjoys a 100% occupancy rate with a weighted average lease term of over 10 years.

Zoned Properties Inc. (OTCQB: ZDPY) is a technology-driven property investment company focused on acquiring value-add real estate within the regulated cannabis industry in the United States. The company aspires to innovate within the real estate development sector, focusing on direct-to-consumer real estate that is leased to best-in-class cannabis retailers.

The company is redefining the approach to commercial real estate investment through its standardized investment process backed by its proprietary property technology. Zoned Properties has developed a national ecosystem of real estate services to support its real estate development process, including a commercial real estate brokerage and a real estate advisory practice.

With a decade of national experience and a team of experts devoted to the emerging cannabis industry, Zoned Properties is addressing the specific needs of a modern market in highly regulated industries. The company targets commercial properties that face unique zoning or development challenges, identifies solutions that can potentially have a major impact on their commercial value and then works to acquire the properties while securing long-term, absolute-net leases.

Zoned Properties targets commercial properties that can be acquired and rezoned for specific purposes, including the regulated and legalized cannabis industry. It does not grow, harvest, sell or distribute cannabis or any substances regulated under United States law.

The company is headquartered in Scottsdale, Arizona.

Portfolio

The company’s investment properties are located in Arizona, Michigan and Illinois, with 100% occupancy and a weighted average lease term over 10 years. Each of the company’s leased properties is occupied by a commercial cannabis tenant. The company is expecting rental revenue from its property investment portfolio of greater than $2.5 million in calendar-year 2024.

Zoned Properties maintains a portfolio of properties that it owns, develops and leases. As of February 2024, the company leases land and/or building space at the six properties in its portfolio to licensed and regulated cannabis tenants in areas with established cannabis regulations and zoning procedures. Four of the leased properties are zoned and permitted as regulated cannabis retail dispensaries, and two of the leased properties are zoned and permitted as regulated cannabis cultivation and processing facilities.

The company considers the two cultivation sites in its portfolio as legacy properties and may consider selling or leveraging those properties to unlock equity and create capital availability in the future. The Zoned Properties investment thesis has evolved over the years as the cannabis industry has emerged, and the company is currently focused on investing capital into direct-to-consumer properties, located in state-markets with robust cannabis consumer demand in the industry.

Zoned Properties is in pursuit of property acquisitions that can be characterized as consumer-facing, retail dispensary properties that are positioned to be leased to retail dispensary cannabis tenants under net leasing structures. As of September 2023, the company has agreements in place to acquire new investment properties with new cannabis tenants located in Arizona, Missouri and Illinois. The company plans to initiate and target its investment process in Ohio and Maryland.

With a strategic shift in focus to direct-to-consumer real estate that is leased to best-in-class cannabis retailers in the industry, the company will continue to utilize its competitive edge when identifying excellent investment properties. Zoned Properties has a full pipeline of acquisition prospects and continues to utilize an extremely disciplined capital allocation approach.

Market Opportunity

According to MJBizDaily, a publication that has covered the North American cannabis business since 2011, combined U.S. medical and recreational cannabis sales were estimated at approximately $33.6 billion at the end of 2023, largely driven by the opening of new adult-use markets.

The publication projects that combined U.S. retail cannabis sales will reach upwards of $53.5 billion by 2027, according to an analysis published in its volume of cannabis market research, the MJBiz Factbook.

As of February 2024, 38 U.S. states had legalized medical, recreational or other limited use of cannabis. The Pew Research Center reports that, in January 2023, there were more than 11,000 licensed cannabis dispensaries in the U.S. In addition, global research firm IBISWorld reports that more than 40,000 U.S. localities have adopted regulations governing cannabis usage, production, processing and/or dispensing.

Management Team

Bryan McLaren is the Chairman and CEO of Zoned Properties. Previously, he worked as a Sustainability Consultant for Waste Management Inc., where he led the strategic development and operational implementation of zero-waste programs for clients. He was also appointed as a city Sustainability Commissioner. He holds a bachelor’s degree in business administration from the University of San Diego, a master’s degree in sustainable development from Northern Arizona University, an executive master’s degree in business leadership from Arizona State and an MBA with a specialty in sustainable development.

Berekk Blackwell is the President and COO of Zoned Properties. He previously spent time in developing domestic and international markets for Kahala Brands, a conglomerate of over 15 QSR franchises, including Cold Stone Creamery and Blimpie Subs. He later worked on developing QSR concepts for Revamp Corp. in Tokyo. After returning to the U.S., he served as president of Daily Jam, a limited-service breakfast and brunch chain. He holds a bachelor’s degree in business administration in finance from Fort Lewis College.

Patrick Moroney is the Director of Real Estate Acquisitions for Zoned Properties. Previously, he was one of the most successful Associate Brokers at Kidder-Mathews, focusing primarily on the regulated cannabis industry. He also worked as a commercial real estate broker rep at Cushman & Wakefield and Colliers International. He graduated from Arizona State University, after which he spent four years as a local sports broadcaster in Georgia and Iowa.

Kyle Gere is the Director of Advisory Services at Zoned Properties. He has years of licensing experience across multiple U.S. states in the medical and recreational cannabis markets. Since 2015, he has been involved in cannabis real estate transactions in Arizona and Michigan, managing a portfolio of medical marijuana properties. He attended Northern Arizona University, graduating with a bachelor’s degree in business administration in both management and marketing.

Zoned Properties Inc. (OTCQB: ZDPY), closed Wednesday's trading session at $0.58, up 5.3396%, on 4,329 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.35/$0.80.

Recent News

Bravo Multinational Inc. (OTC: BRVO)

The QualityStocks Daily Newsletter would like to spotlightFathom Bravo Multinational Inc. (OTC: BRVO).

Bravo (OTC: BRVO) is a company actively exploring opportunities in the entertainment, hospitality and technology sectors to generate long-term value through high-growth business ventures. "Bravo is currently focused on pioneering innovative solutions in the digital content landscape, with a goal of providing cutting-edge and diverse content experiences to global audiences. In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.'s assets, making a step toward establishing its flagship offering, TVee NOW(TM). The assets acquired from Streaming TVEE provide Bravo with the technology and foundation to offer streaming services, including video-on-demand (‘VOD') and linear television – encompassing cable and satellite networks through a joint venture with Pythia Experiences," a recent article reads. "Bravo's TVee NOW streaming service will offer some of its content for free, with the rest requiring a subscription service with rates competitive to those of other popular streaming applications… TVee NOW plans to offer a wide range of on-demand content, including movies, series, concerts, and original programming. The service, set for beta launch in Q1 2024, will be accessible across various devices, with dedicated apps on platforms such as Roku, Apple and Google Play stores, reinforcing Bravo's commitment to innovation and audience accessibility."

To view the full article, visit https://ibn.fm/bMJOL

Bravo Multinational Inc. (OTC: BRVO) actively explores opportunities in the entertainment, hospitality and technology sectors to generate long-term value for its shareholders through high-growth business ventures. Currently focused on pioneering innovative solutions in the digital content landscape, the company’s goal is to provide cutting-edge and diverse content experiences to a global audience.

In February 2024, Bravo finalized a deal to acquire Streaming TVEE Inc.’s assets, marking a pivotal step in establishing its flagship offering, aptly named TVee NOW™. The acquired assets provide the company with the technology and foundation to soon offer streaming services including Video-On-Demand (VOD) and linear TV, often referred to as traditional broadcast TV, which encompasses cable and satellite networks, through a joint venture with Pythia Experiences.

TVee NOW™ plans to offer a wide range of on-demand content, including movies, series, concerts and original programming, at minimal or no cost to viewers. The service, set for beta launch in Q1 2024, will be accessible across various devices, with dedicated apps available on platforms such as Roku, Apple and Google Play stores, reinforcing Bravo’s commitment to innovation and audience accessibility.

The company is based in Virginia Beach, Virginia, with a second office soon opening in Las Vegas, Nevada.

Products

TVee NOW’s streaming service will offer a portion of its content for free, catering to the growing demographic of cord-cutters and aligning with the dynamic landscape of advertising-based video on demand (AVOD) streaming. Bravo’s Over-The-Top (OTT) streaming platform is specifically crafted to deliver content directly to viewers via the internet, accessible through a browser or freely downloadable apps on smartphones, tablets and smart TVs.

Bravo’s planned strategic approach for content is to first integrate partnered Free Ad-Supported TV (FAST) channels, programmatic advertising and a tiered revenue sharing model. Additionally, the company plans to complete the deal with Pythia Experiences, enabling a hybrid model comprised of AVOD, utilizing programmatic advertising through ad servers, and Subscription-based Video-on-Demand (SVOD), which the company plans to offer at competitive rates compared to other services. With this model completed, Bravo can bridge the gap until the company can ultimately create its own original content.

Through the asset purchase agreement with Streaming TVEE, Inc., the company obtained exclusive rights, image and likeness, label waivers and exploitation rights for streaming of 117 high-definition music and comedy performances, each offering a director’s cut and multiple camera perspectives. Some of the music artists include Snoop Dogg, H.E.R., Kings of Leon, Alicia Keys and Bone Thugs-N-Harmony, along with comedic performances from Bill Burr, Jim Gaffigan, Kristen Schaal, Rob Delaney and others. This original footage will allow Bravo to recreate shows in diverse formats, which can showcase these concert films in a compelling full-feature format.

Market Opportunity

A report from Fortune Business Insights, a global market research and reporting firm, estimated the global video streaming market at $455.45 billion in 2022. It is projected to grow from $554.33 billion in 2023 to $1.9 trillion by 2030, achieving a CAGR of 19.3% during the forecast period.

Growth drivers, according to the report, include a rising number of users of Video-on-Demand services (YouTube, for example) worldwide and the growing adoption of OTT content providers (like Netflix and Hulu, among many others) by consumers, as well as consumers’ willingness to spend more for streaming video content.

Management Team

Grant Cramer is CEO and Director of Bravo. He has more than 30 years of experience as an actor, writer, director, producer and production executive. As founder and president of Landafar Entertainment and Global Pictures Media, he has overseen development and production of 14 feature films. He executive produced Lone Survivor, November Man and Arctic Dogs. He produced And So It Goes, directed by Rob Reiner and starring Michael Douglas and Diane Keaton. His short film Say Goodnight, Michael won several awards, including the Grand Jury Award at the New York International Independent Film Festival.

Frank Hagan is Bravo’s President and Director. He is an Emmy-nominated producer with over 30 years of experience in the entertainment industry. He is the former Programming Director and GM of QTN. He has produced shows for major networks and companies, including Discovery Channel, History Channel and Relativity Media. Most recently, he served as a consulting producer for Electric Entertainment’s ElectricNOW! and the Saturn Awards and worked as a regular weekly panelist for Outlaw Internet Radio.

Richard Kaiser is CFO and Director of Bravo. He is also CFO at BioForce Nanosciences Holdings Inc. and Gold Rock Holdings Inc. He serves on the board of Element Global Inc., a wholly owned subsidiary of BioForce Nanosciences Holdings Inc. He previously directed investor relations for Royal Standard Minerals Inc. and Scorpio Mining Inc. He was also Head of Corporate Communication and Investor Relations at Air Packaging Technologies Inc. and Puff Pack Industries Inc.

Kayla Slick is COO and Director at Bravo. She has more than 15 years of experience in various industries, including finance, healthcare, technology, retail, hospitality and entertainment. She co-founded The PRIME Symposium and significantly increased revenues for INSIDE Public Accounting. She held positions at Interactive Digital Solutions, where she founded the Sales Development Program and was later promoted to Marketing Communications Director for IDS’ flagship virtual patient observation product.

Bravo Multinational Inc. (OTC: BRVO), closed Wednesday's trading session at $0.16, up 6.277%, on 18,500 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.111/$0.95.

Recent News

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF)

The QualityStocks Daily Newsletter would like to spotlightFathom Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) .

Tartisan Nickel (CSE: TN) (OTCQB: TTSRF) is a Canadian mineral and battery metals exploration and mining development company. The company's Kenbridge Nickel Project, located in the Kenora Mining District in the Province of Ontario, is an advanced-staged nickel deposit with a measured, indicated and inferred resource that has an existing 622-meter three compartment shaft. "As the world looks to utilize electric vehicles (‘EVs') in an effort to reduce air pollution, demand for EV battery metals is on the rise," a recent article reads. "Nickel is one of these in-demand battery metals, and there are few new, high-grade development projects ready to meet this opportunity. Silver, zinc, copper and even lead are also part of this transformation in the EV sector. Tartisan Nickel Corp. is an advanced stage mining development company in a mining-friendly jurisdiction. The company is headquartered in Toronto, Ontario, Canada."

To view the full article, visit https://ibn.fm/p9KnT

Tartisan Nickel Corp. (CSE: TN) (OTCQB: TTSRF) is a Canadian mineral and battery metals exploration and mining development company. Tartisan’s flagship asset is the Kenbridge Nickel Project. Located in the Kenora Mining District, in the Province of Ontario, the Kenbridge Nickel Project is an advanced staged nickel deposit with a measured, indicated and inferred resource and has an existing 622-meter three compartment shaft.

As the world looks to utilize electric vehicles (EVs) in an effort to reduce air pollution, demand for EV battery metals is on the rise. Nickel is one of these in-demand battery metals, and there are few new, high grade development projects ready to meet this opportunity. Silver, zinc, copper and even lead are also part of this transformation in the EV sector. Tartisan Nickel Corp. is an advanced stage mining development company in a mining friendly jurisdiction. The company is headquartered in Toronto, Ontario, Canada.

Projects

The company’s flagship Kenbridge Nickel Project is in the north-central part of the Atikwa Lake area and the south-central part of the Fisher Lake Area in the Kenora Mining District, approximately 70 kilometers east-southeast of the Town of Kenora in northwestern Ontario. The property is accessible via gravel roads from paved Highway 71. The Kenbridge Nickel Project is covered by patented and unpatented mining claims totaling 10,150 acres.

Tartisan’s project portfolio also includes:

  • The Don Pancho Manganese Silver Zinc Project is in a prolific polymetallic mineral belt in central Peru with several operating mines in the area, including the world-class Iscaycruz and Yauliyacu polymetallic mines, operated by Glencore Xstrata PLC, which are located 50 kilometers to the north-northwest. Additionally, Travail Mining Corporation’s Santander silver-lead-zinc mine is located just nine kilometers to the east and Buenaventura’s silver-lead-zinc Uchucchacua mine, which produced 10 million ounces of silver in 2011, is located 63 kilometers to the north.
  • The Turtle Pond Nickel Copper Project includes 105 staked units covering approximately 5,440 acres in northwestern Ontario, approximately 40 kilometers south of the town of Dryden in the Turtle Pond and Ukik Lake area. The claims are located approximately 70 kilometers east of the company’s flagship Kenbridge Nickel Project.
  • The Sill Lake Lead Silver Project is located approximately 30 kilometers north-northeast of Sault Ste. Marie in Vankoughnet Township in the Sault Ste. Marie Mining District of Ontario. The Sill Lake Property comprises 57 contiguous mining claims totaling approximately 2,850 acres.

Market Opportunity

A report by Grand View Research, a market research and consulting company, estimated the global nickel mining market to be worth $50.4 billion in 2022 and projected the market will grow to a value of more than $84.04 billion by 2030, achieving a CAGR of 6.6% over the forecast period.

Nickel alloy is a component of EV, portable electronics and power tool batteries. In addition, nickel is one of the key raw materials of stainless steel. Hence, development in the EV industry and growth in stainless steel end-use industries such as construction, consumer durables and machinery and equipment contribute to the growth of the market.

According to the Nickel Institute, the industry association for the world’s nickel producers, over two-thirds of the world’s nickel is currently utilized in the production of stainless steel.

Management Team

D. Mark Appleby is President, CEO and Director of Tartisan Nickel. He has more than 37 years of experience in a variety of disciplines relating to investment banking, corporate finance and capital markets. His career began at Manulife in the equity and fixed income departments. He later joined First Boston Canada, where he reached the position of Vice President, Bond Trading. Subsequently, he has worked as an investment executive with Scotia Mcleod Inc. and is co-founder of The Atlantis Group. He also served as a Director of Guyana Goldfields Inc. for five years.

Omar Gonzalez is CFO of Tartisan Nickel. He has over 20 years of experience in audit and assurance in South America, as well as five years of public and private audit practice, financial analysis and corporate development in Canada. He has led many assurance and non-assurance engagements for companies in the energy, mining and natural resources, real estate, manufacturing and consumer business sectors. He is a Chartered Professional Accountant in Venezuela and holds a bachelor’s degree in accounting from the Universidad Santa María in Caracas.

Tartisan Nickel Corp. (OTCQB: TTSRF), closed Wednesday's trading session at $0.1325, up 3.2736%, on 95,553 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.04685/$0.139.

Recent News

SUIC Worldwide Holdings Ltd. (OTC: SUIC)

The QualityStocks Daily Newsletter would like to spotlightFathom SUIC Worldwide Holdings Ltd. (OTC: SUIC) .

SUIC CEO Hank Wang recently joined Bell2Bell Podcast host Stuart Smith to discuss the company's operations and business model, recent milestones, and plans for 2024

The venture financing and support company, through its I.Hart Group and Boom Fintech subsidiaries, has entered into agreements that set the stage for significant expansion

SUIC's I.Hart Group recently signed a brand corporation agreement with 7-Eleven, expected to promote the company's long-term growth

The company's Boom Fintech is working on financing that will support the creation of a revolutionary B2B financing platform and boost supply chain integration for suppliers

SUIC expects to significantly expand its product markets, making 2024 its best year yet, according to Hank

SUIC Worldwide Holdings (OTC: SUIC), a provider of research and development, venture financing, and investment for public and private companies, was featured in a recent episode of The Bell2Bell Podcast. SUIC CEO Hank Wang joined host Stuart Smith to discuss the company's operations and business model, recent milestones, and plans for 2024 (https://ibn.fm/dy633).

SUIC Worldwide Holdings Ltd. (OTC: SUIC) provides research and development, venture financing and investment for private and public companies that develop products and services in the areas of Internet of Things, cloud computing, mobile payments, Big Data, blockchain, artificial intelligence and global franchising. The company seeks to enhance and streamline existing processes and establish new and exciting business models that will create revolutionary products and services.

SUIC is the largest shareholder and major operating partner of Beneway Holdings Group. The I.Hart Group, a subsidiary of Beneway, currently operates 150 global chain and franchised locations under a variety of brands. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups to expand and achieve its target of 750 chain and franchise locations in the near future.

The company is headquartered in Flushing, New York, with offices in San Francisco, Taiwan and Malaysia.

Portfolio

SUIC works with Beneway in several business ventures, with focus on the following:

  • Fintech – Through Boom Fintech, the major subsidiary of Beneway USA, the company holds nine revolutionary fintech patents. Boom Fintech integrates payment systems, electronic invoice devices, mobile cash registers, POS system devices and ERP, as well Big Data + AI and other services, to ALL-IN-ONE products that provide standardized intellectual property that’s modular to all industries, from chain department stores to night market vendors. Beneway Holdings Group connects borrowers and lenders, building strategic partnerships by bridging the various stakeholders to provide a holistic financial delivery ecosystem and to integrate advanced systems and finance its global merchants and franchisees.
  • Food Industry Supply Chain Integration – SUIC and Beneway will partner with international trade financiers to support the huge demand for raw material import/export between the U.S. and Asia. SUIC and Beneway are looking to raise funds from an IPO and the capital markets to support mergers and acquisitions of U.S. mid- and upper-stream food industry suppliers.
  • Global Chain and Franchise Expansion – Through I.Hart catering group, SUIC and Beneway are working to bring reputable and distinguished overseas food product brands to the U.S. and around the world. It is working on integrating more successful chains to enter the U.S. chain and franchise market in all 50 states. It is replicating its successful multi-branding business model and teaming up with top U.S. real estate firms, shopping malls and associated groups for faster expansion.
  • Other Supply Chain Integration – Beneway has identified several additional industries for future expansion, including medical and health care, high-tech digital AI systems, environmental protection and energy-related production.

Market Opportunity

An analysis by Growth Market Reports, a full-service market research and business consulting organization, estimated that the value of the global Asian food market was $437.15 billion in 2022. The market value is projected to reach approximately $805.08 billion by 2031, expanding at a CAGR of 7.1% during the forecast period.

Asian cuisine is well known for its diversity, with a wide range of flavors, ingredients and cooking techniques influenced by various factors such as climate, geography, history and cultural practices. The report states that Asian food outlets are expanding at a tremendous rate in the U.S. and Europe due to rising consumer demand. Demand is driven by various factors, including the growing interest in global authentic flavors and the nutritional benefits that Asian food offers. Consumers have become increasingly exploratory with their food choices, according to the report.

McKinsey Consultants estimate that, by 2025, the global supply chain financial market will reach $20 trillion. At present, 60% of the global participants are small and medium-sized retail companies, representing the target customers of SUIC and its subsidiary. Recent Juniper Research shows that global digital commerce transaction value will also pass $20 trillion by 2027.

Management Team

Hank Wang is CEO of SUIC. Since 2018, he has served as CEO of the I.Hart Group. Prior to joining I.Hart, he was Secretary General of Taiwan Quantitative Hedging Development Association. He graduated from Tamkang University in Taiwan with a Bachelor of Finance degree.

Elena Lin is associate CFO of SUIC. She previously served as CEO of Monga Chicken. In 2015, she was recognized as one of Taiwan’s Top 100 Managers of the Year. She holds a master’s degree from the Kaohsiung University of Hospitality and Tourism’s Institute of Food Culture and Catering Innovation in Taiwan.

Elton Han is associate CTO of SUIC. He is also currently Director of Food and Beverage Development for the I.Hart Group. He also holds a position with the Taiwan International Young Chefs Association. He previously served as Executive Chef of Hanbilou, Huashan Guanzhi, Daye Group.

SUIC Worldwide Holdings Ltd. (OTC: SUIC), closed Wednesday's trading session at $1.74, even for the day, on 40 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.95/$3.00.

Recent News

Advanced Gold Exploration Inc. (CSE: AUEX) (FSE: 4TG) (OTC: AUHIF)

The QualityStocks Daily Newsletter would like to spotlightFathom Advanced Gold Exploration Inc. (CSE: AUHIF) (FSE: 4TG) (OTCQB: AUHIF) .

Advanced Gold Exploration (CSE: AUEX) (OTC: AUHIF) (FSE: 4TG), a junior mining company bringing an entirely different approach to the mining industry, released a statement noting the interest in copper and the recent increases in the price of the metal. The company is interested in copper and its role in electric vehicle development as well as reducing greenhouse-gas emissions and is developing its own copper project, Buck Lake. The statement noted that copper is instrumental in the commodities super cycle and that the world needs more copper, making exploration key in the supply. The company observed that its Buck Lake property, which is a volcanogenic massive sulphide deposit ("VMS")-style copper prospect with high-grade copper intersections in drill holes and channel samples, covers nearly 4,000 hectares and has multiple copper and zinc showings from past work and recent prospecting. "Although we are focused on gold, we have copper," said Advanced Gold Exploration CEO James Atkinson in the press release. "Our Buck Lake Project consists of a partially drilled VMS-style of copper deposit. We are actively looking for a partner to join us in the exploration of this exciting project. This is an opportunity to continue to expand the known mineralization but also to apply modern exploration techniques to this large property with many mineralized occurrences. . . . We believe in the potential of the Buck Lake Property and, in the light of our newly stated focus on gold exploration, we will continue discussions with potential partners to advance the project freeing us to concentrate on our exciting gold projects."

To view the full press release, visit https://ibn.fm/Hxm3b

Advanced Gold Exploration Inc. (CSE: AUEX) (OTC: AUHIF) (FSE: 4TG), formerly Advance United Holdings Inc., is a junior mining company bringing an entirely different approach to the mining industry. Advanced Gold Exploration doesn’t intend to become a mining company. Rather, it has acquired a portfolio of undervalued gold properties and is increasing their value through the application of modern technology. The object is to eventually monetize the projects to add value for its shareholders.

Advanced Gold Exploration has a growing pipeline of similar properties that it is looking to acquire. The company is involved exclusively in the acquisition and advancement of past gold projects – with no intent to bring them back into production. It leaves the actual gold mining to others who are experts in that area.

Advanced Gold Exploration’s expertise is in identifying and acquiring undervalued properties with significant historical work which were previously not economically viable, but that the company believes have economic value at today’s gold prices. Advanced Gold Exploration funds the reworking of historic data and applying modern technology to underwrite new qualified reports that document quantifiable resources and reserves to current standards, thereby recognizing the current value of the projects.

The company’s purpose is to bring immediate and long-term value to its partners and shareholders while seeking to eliminate exploration risk. Advanced Gold Exploration believes that the future of gold is strong, and it will be part of that future.

The company is headquartered in Toronto.

Projects

The Melba Property is the site of a former producing gold mine located about 15 kilometers north of the gold mining center of Kirkland Lake, Ontario. The project is located in the Abitibi Greenstone Belt, part of the largest gold producing area of Canada. Visible gold can be identified in quartz veins on the surface and high-grade gold intersections have been obtained in drilling by AUEX. No exploration has been carried out on the extensions of the veins to the north or south of the surface exposures in swamp covered areas.

The Doyle Property lies in the Batchawana Greenstone Belt located north of Sault Ste. Marie, Ontario. Past drilling identified high-grade gold deposits in three areas of the property. Follow up studies are needed on all three sites. Exploration has not been carried out to follow-up the high-grade gold intersections. Further work will focus on expanding the areas of known gold mineralization.

The Landrum Property in Edgefield County, South Carolina, is in the Carolina Gold Belt, home of at least five past producing gold mines and one currently producing gold mine. The area was the site of the first gold rush in the U.S. in the early 1800s, predating 1849 California. The area has recently become of interest due to gold bearing intersection on a nearby property where 62.5 meters graded 8.5 G/t gold in a recent drillhole. Gold can still be panned in some streams in the area. Identified veins consist of silicified zones generally made up of 20-50% and vary in thickness from less than a meter to 10 meters.

The Paint Lake Road Property is located in Wawa, Ontario, and is less than five kilometers from Wesdome’s operating Mishi Open Pit gold mine. Gold deposits have been found to the north, east and south of the property. A recent geophysical survey on the neighboring property has pointed to a prospective mineralized horizon which appears to trend onto the property.

Market Opportunity

The World Gold Council, the industry association for the world’s gold producers, estimated in 2023 the physical financial gold market, which is made up of bars, coins, gold ETFs and central bank reserves, is worth nearly $5 trillion. The council reports that gold mine production adds approximately 3,500 tons of the precious metal to the world’s supply annually, equivalent to about 2% growth.

Recently the gold price has reached new highs on multiple days and is tracing a trend upward.

This historical scarcity and relatively slow production of new supply, as compared to other commodities, is a primary reason gold has retained its value for millennia, according to the council.

Management Team

James Atkinson, M.Sc., P. Geo., is CEO of Advanced Gold Exploration. An experienced exploration geologist and project manager with over 50 years of experience, he has spent his career in mineral exploration and mining. He has designed and managed multimillion dollar programs searching for and discovering various commodities, including industrial minerals. These projects involved geophysical, geochemical and drilling programs, as well as prospecting and geological mapping. He has also negotiated options and purchase deals for mineral properties and raised financing for exploration. He recently completed a transaction which resulted in cash and shares to the company. The result was a special distribution of publicly trading shares to the existing shareholders.

Andrew Ramcharan, Ph.D., P. Eng., is President of Advanced Gold Exploration. He has 20 years’ unique experience in the mining industry, which includes investor relations, project evaluation, operations, capital markets, consultancy and investment banking. He has a track record of growing companies significantly, with recent success at Roscan Gold with over $100 million of value creation in less than 14 months. He has created and implemented investor relations policies and corporate strategies with significant success. He completed over 300 project evaluations globally on many commodities, proposed over 40 for different investment strategies and completed two majors take over (worth of $800 million and $1.5 billion in capital cost). He directly assisted in putting four mines in production and significant growth of numerous companies, including IAMGOLD. At Sprott, he was conducting project evaluation and successfully deployed over $500 million – the most deals in any year.

Radovan Danilovsky, CIM, is CFO of Advanced Gold Exploration. He is an experienced small-cap executive in the junior mining sector. He is also an experienced investment manager and currently is a registered Portfolio Manager with Wealthera Inc. He has served as a Managing Director, Portfolio Manager and Chief Compliance Officer of Orthogonal Capital Management Corp. Prior to that, he was an investment analyst at Accilent Capital Management Inc. He is a graduate of the University of Toronto and earned master’s degrees from UPMC Sorbonne University and ESSEC Business School in Paris.

Advanced Gold Exploration Inc. (OTC: AUHIF), closed Wednesday's trading session at $0.02, even for the day. The average volume for the last 3 months is and the stock's 52-week low/high is $0.0189/$0.095.

Recent News

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF)

The QualityStocks Daily Newsletter would like to spotlight Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF).

Copper is a heavily traded metal that has different applications in a number of industries. The metal's producers in China plan to export nearly 100,000 metric tons, their highest volume in more than a decade. Their objective is to cool a rally that has pushed prices toward new highs. Producers in the East Asian country are selling into the rally, driven by a frenzy that saw prices of the red metal on the London Metal Exchange reach $10,208 per metric ton. This figure is about $600 short of its March 2022 high, when copper reached $10,845 a metric ton. Sources theorize the arbitrage between the Shanghai Futures Exchange and the London Metal Exchange is making it profitable to export the red metal. One source in logistics adds that producers have already begun asking about costs of moving copper to warehouses under the London Metal Exchange from China. A different source at a copper smelter in China also revealed that it expects to export about 20,000 tons of copper monthly if prices on the London Metal Exchange remain at the current level. With the demand for copper poised to rise over the coming years as green-energy penetration gathers steam, exploration companies such as Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) could be poised for explosive growth in investor interest.

Arizona Metals Corp. (TSX: AMC) (OTCQX: AZMCF) is a mineral exploration company engaged in advancing precious and base metal deposits in the state of Arizona. Its flagship copper-gold-zinc-silver asset is the Kay Mine Project, located in Yavapai County. The company also owns Sugarloaf Peak gold project in La Paz County.

The company in October 2022 received permit approval from the Bureau of Land Management (BLM) for two new drill pads, located approximately 1,200 meters west of the Kay Mine Deposit. These new pads will allow for testing of the company’s Western Target, while also allowing for drilling of additional coincident anomalies located between the Central and Western Targets. Construction of the drill road for the Central Target (located 500 meters west of the Kay Mine Deposit) is currently underway, with drilling expected to begin in November 2022. Road construction for the Western Target will begin upon confirmation of BLM acceptance of the company’s posted bond, with drilling expected to commence in Q1 2023.

The company is fully funded, with $60 million in cash as of June 30, 2022, to complete the remaining 18,000 meters planned for the Phase 2 program at Kay, as well as an additional 76,000 meters in the Phase 3 program (budgeted at $27 million), which will be used to test the numerous parallel targets heading west of the Kay Deposit, as well as the northern and southern extensions of the Kay Deposit.

Arizona Metals Corp. is based in Toronto, Canada.

Projects

Arizona Metals Corp. owns 100% of the Kay Mine property in Yavapai County, which is located on a combination of patented and BLM claims totaling 1,300 acres that are not subject to any royalties. An historic estimate by Exxon Minerals in 1982 reported a “proven and probable reserve of 6.4 million short tons at a grade of 2.2% copper, 2.8 grams per ton gold, 3.03% zinc, and 55 grams per ton silver.” The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported by Exxon, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a “qualified person” (as defined in National Instrument 43-101 – Standards of Disclosure for Mineral Projects) before the historic estimate can be verified and upgraded to be a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

The company also owns 100% of the Sugarloaf Peak Property in La Paz County, which is located on 4,400 acres of BLM claims. Sugarloaf is a heap-leach, open-pit target and has a historic estimate of “100 million tons containing 1.5 million ounces (of) gold” at a grade of 0.5 grams per ton. The historic estimate at the Sugarloaf Peak Property was reported by Westworld Resources in 1983. The historic estimate has not been verified as a current mineral resource. None of the key assumptions, parameters, and methods used to prepare the historic estimate were reported, and no resource categories were used. Significant data compilation, re-drilling and data verification may be required by a qualified person before the historic estimate can be verified and upgraded to a current mineral resource. A qualified person has not done sufficient work to classify it as a current mineral resource, and Arizona Metals is not treating the historic estimate as a current mineral resource.

Market Opportunity

The World Gold Council, an industry association representing gold producers with hundreds of mining operations in nearly 50 countries around the world, reports that global demand for gold during the first six months of 2022 was 2,189 tons, a 12% increase in demand over the same period in 2021. Demand came primarily from gold bar and coin investors, jewelry consumers, central bank purchases to bolster currency reserves and technology manufacturing.

The average price per ounce for the period was $1,871, marking a 1% year-over-year increase. The council reported gold mine production for the period was up 3% over 2021 at 1,764 tons. For the remainder of 2022 and into 2023, the council projects flat gold demand with possible slight increases in gold mine production. The council notes that unpredictable geopolitical factors, the Ukraine war for example, and likelihood of global economic slowdown could have significant near-term impact on gold demand and prices.

Management Team

Marc Pais is President and CEO of Arizona Metals. He previously founded and served as President of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. He has seven years of experience as a Mining Analyst, with a focus on precious metals development companies. He holds a B.Sc. in Geological Engineering (Mineral Exploration) from Queen’s University in Canada.

David Smith is the Vice President, Exploration of Arizona Metals. He has 30 years of global precious metals exploration experience, including codiscovery of the Solidaridad/La Sabila deposit in Mexico with deposits estimated at 1 million ounces of gold. His core areas of expertise are managing mineral projects from acquisition to exploration, resource modeling and mineral project development. He holds an M.Sc. from the University of Oregon and an MBA from Pinchot University/Presidio Graduate School.

Paul Reid is the Executive Chairman of Arizona Metals. He previously founded and served as Executive Chairman of Telegraph Gold (listed as Castle Mountain Mining), which was acquired by Equinox Gold, a TSX-listed mining company. Paul has extensive experience as an Investment Banking professional, involved in raising capital, go-public transactions, and advisory services.

Arizona Metals Corp. (OTCQX: AZMCF), closed Wednesday's trading session at $1.56, off by 3.7037%, on 129,919 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $1.21/$3.0595.

Recent News

D-Wave Quantum Inc. (NYSE: QBTS)

The QualityStocks Daily Newsletter would like to spotlight D-Wave Quantum Inc. (NYSE: QBTS).

D-Wave Quantum Inc. (NYSE: QBTS) ("D-Wave"), a leader in quantum computing systems, software, and services, will be participating in this month's 19th Annual Needham Technology, Media and Consumer Conference. The three-day conference is scheduled for May 14–16, 2024.

D-Wave CEO &Dr. Alan Baratz is slated to participate in a fireside chat that begins at 1:30 p.m. ET on May 16. During the discussion, Dr. Baratz will provide an overview of the company's latest advancements and its strategic direction, as well as the measurable outcomes that quantum computing is delivering for businesses today. An archived version of the webcast will be made available on D-Wave's website following the event. In addition, Dr. Baratz will meet with investors and interested parties in one-on-one meetings during the event.

To view the fireside chat, visit https://ibn.fm/fIliy

To view the full press release, visit https://ibn.fm/Bc1Gm

D-Wave Quantum Inc. (NYSE: QBTS) is a leader in quantum computing systems, software and services focused on delivering customer value via practical quantum applications for problems such as logistics, artificial intelligence, materials sciences, drug discovery, scheduling, fault detection and financial modeling. As the only provider building both annealing and gate-model quantum computers, the company is unlocking commercial use cases in optimization today, while building the technologies that will enable new solutions tomorrow.

D-Wave is a pioneer in quantum computing, with a history of delivering the world’s first commercial quantum computer; the first real-time quantum cloud service; countless hardware and software product and research milestones; and the planned first cross-platform quantum solution which will deliver both annealing and gate-model quantum computers to customers via an integrated platform. Its current commercial product offerings include: Advantage™ (fifth generation quantum computer), Leap™ (quantum cloud service), Launch™ (quantum computing onboarding service) and Ocean™ (full suite of open-source programming tools).

D-Wave’s relentless pursuit of practical quantum computing has resulted in the technology being used today by some of the world’s most advanced enterprises – more than 25 of the Forbes Global 2000 use D-Wave.

D-Wave’s commercial customers include blue-chip industry leaders like Volkswagen, Accenture, BBVA, NEC Corporation, Save-On-Foods, DENSO and Lockheed Martin. The company boasts an extensive IP portfolio featuring more than 200 issued U.S. patents and over 100 peer-reviewed papers published in leading scientific journals.

Founded in 1999, D-Wave is the world’s first commercial supplier of quantum computers. With headquarters and the Quantum Engineering Center of Excellence based near Vancouver, Canada, D-Wave’s U.S. operations are based in Palo Alto, California.

Advantage™ Quantum Computer

 

With the Advantage™ Quantum Computer, D-Wave has incorporated two decades of experience and over 10 years of customer feedback to create the first and only quantum computer designed for business. The platform features a new processor architecture with over 5,000 qubits and 15-way qubit connectivity. This is 2.5x more connections and more than double the number of qubits than the company’s previous generation quantum computer.

D-Wave’s quantum computers, first located in its facilities in British Columbia, have been available to North American users through its Leap™ quantum cloud service since 2018. It has since introduced new Advantage systems in Julich, Germany, and most recently, Marina Del Rey, California, which marked the availability of the first Advantage quantum computer physically located in the United States.

That new deployment is part of the USC-Lockheed Martin Quantum Computing Center (QCC) hosted at USC’s Information Sciences Institute (ISI), a unit of the University of Southern California’s prestigious Viterbi School of Engineering. Additionally, Amazon Web Services (AWS) and D-Wave announced that the U.S.-based system is available for use in Amazon 2racket, expanding the number to three different D-Wave quantum systems available to AWS users.

Leap Quantum Cloud Service

 

D-Wave’s customers interface with its systems through the Leap™ quantum cloud service. Leap delivers immediate, real-time access to the company’s Advantage quantum computer and quantum hybrid solver service, all with enterprise-class performance and scalability.

Leap allows developers proficient in Python to get started building and running quantum applications. Through a seamless and secure cloud-based connection, users can easily start solving complex problems of up to 1 million variables and 100,000 constraints.

Using Leap, D-Wave customers have developed quantum hybrid applications for use cases in manufacturing, logistics, financial services, life sciences, materials science, retail and transportation. By eliminating the need to wait hours, days or weeks to get good answers to a broad array of problems, D-Wave is helping businesses move forward.

D-Wave Launch

D-Wave Launch™ is the company’s onboarding platform aimed at helping businesses easily start their quantum journey. Through this program, D-Wave’s team of experts and partners aid enterprises in identifying best use cases for quantum and work with them to develop a proof of concept and production pilot.

From there, the team coordinates with customers to get their hybrid quantum applications up and running, providing ongoing Leap quantum cloud access to ensure the application is operating smoothly and delivering real business value.

Target Verticals

While the potential applications for quantum computing are effectively limitless, D-Wave has identified a number of industry verticals as key areas of focus for its quantum architecture, providing case studies for each. These include:

  • Manufacturing – D-Wave worked with Volkswagen to identify a commercial optimization application, the binary paint shop problem, which was run on D-Wave’s hybrid solver service. The solver outperformed four purely classical methods on problem sizes at commercial scale (N=3,000). In a separate project, similar inputs were tested using a leading ion trap system, which failed to find any commercial solution.
  • Life Sciences – Menten AI makes use of D-Wave quantum computing to assist in the design of novel therapeutic peptides—short strings of amino acids that can act as potent drugs. With the rise of COVID-19, D-Wave’s Advantage system made it possible to identify molecules that might be especially well-suited for binding and inhibiting the related spike protein, producing several promising peptide designs.
  • Finance – Multiverse Computing, a leader in developing quantum solutions for the financial sector, leveraged D-Wave’s hybrid solver service in a collaboration with BBVA, one of the world’s largest financial institutions. Multiverse demonstrated management strategies that far exceeded the granularity of traditional returns in a fraction of the time, helping BBVA identify a low-risk portfolio for investment.

Market Opportunity

The quantum computing total addressable market is projected to grow between $450 billion and $850 billion over the next 15 to 30 years, with between $5 billion and $10 billion of anticipated TAM growth coming in the next three to five years, according to Boston Consulting Group. Driving factors behind this growth include rising investments in quantum computing tech by governments and an increasing number of commercial use-cases.

Forward-thinking organizations see quantum as an opportunity to move ahead of the competition. From finding efficiencies and reducing waste to decreasing time to solution and solving problems abandoned due to complexity, the business value is real. According to data from 451 Research, 40% of large enterprises are already experimenting with quantum computing.

D-Wave is strategically positioned – in an industry with significant barriers to entry – as evident by a decades-long track record serving a roster of blue-chip customers. The company is singularly focused on helping its customers achieve clear value by leveraging quantum computing in practical business applications. With a full stack of systems, software, developer tools and services, D-Wave is working to enable enterprises, governments, developers and researchers to access the power of quantum computing, thereby providing an intriguing opportunity for prospective investors.

D-Wave’s current investor base includes PSP Investments, Goldman Sachs, BDC Capital, NEC Corporation, Aegis Group Partners and In-Q-Tel.

Leadership Team

Dr. Alan Baratz has served as the CEO of D-Wave since 2020. Previously, as Executive Vice President of R&D and Chief Product Officer, he drove the development, delivery, and support of all of D-Wave’s products, technologies, and applications. Dr. Baratz has over 25 years of experience in product development and bringing new products to market at leading technology companies and software startups. As the first president of JavaSoft at Sun Microsystems, he oversaw the growth and adoption of the Java platform from its infancy to a robust platform supporting mission-critical applications in nearly 80 percent of Fortune 1000 companies. He has also held executive positions at Symphony, Avaya, Cisco, and IBM. Dr. Baratz holds a doctorate in computer science from the Massachusetts Institute of Technology.

John Markovich is the company’s CFO. He brings to D-Wave over three decades of experience working with rapidly growing private and public technology companies across all stages of development. Mr. Markovich has directed the finance, accounting, tax, treasury, M&A, legal, operations, customer service, IR, HR, and IT functions for companies ranging from privately held pre-revenue startups to an NYSE-listed Fortune 500 multi-national company with over $1.2 billion in annual revenue. During his career, he has negotiated and closed over 150 debt, equity, M&A, and joint venture transactions exceeding $2.5 billion in value; over a dozen private placements; nearly a dozen M&A transactions; and several international joint ventures. Mr. Markovich holds a BS in Business from Miami University and an MBA from the Michigan State Graduate School of Business.

D-Wave Quantum Inc. (NYSE: QBTS), closed Wednesday's trading session at $1.36, off by 1.4493%, on 2,119,436 volume. The average volume for the last 3 months is and the stock's 52-week low/high is $0.3962/$3.20.

Recent News

Correlate Energy Corp. (OTCQB: CIPI)

The QualityStocks Daily Newsletter would like to spotlight Correlate Energy Corp. (OTCQB: CIPI).

Correlate (OTCQB: CIPI) is a distributed energy solutions company focused on solar energy installation opportunities as well as other clean energy infrastructure improvements. As federal government incentives and decreasing costs of solar installation help to scale clean energy adoption across the United States, CIPI is positioned for growth. "We have a constant conveyor belt of a maturity of opportunities which allow us to smartly invest in different parts of the business," a recent article quotes Correlate Energy President and CEO Todd Michaels as saying. "Solar is the most applicable tech right now. It's beating the grid for cost. You can easily do a 10% to 20% discount of what a person pays the local utility."

To view the full article, visit https://ibn.fm/DpOz1

Correlate Energy Corp. (OTCQB: CIPI) is a publicly-traded company strategically positioned to capitalize on America’s unstoppable trend toward decentralized energy generation.

The energy grid in the U.S. is insufficient for the booming clean energy trend, and current infrastructure is limiting green energy distribution. Constructing the needed infrastructure to address this demand imbalance will cost billions and be far too slow, positioning decentralized systems, like those on offer from Correlate, in a key position for heightened demand.

Correlate has identified several key economic drivers powering the decentralized energy trend, including:

  1. Real Cost Savings – Customer pays zero money down and gets an instant electrical price discount to current rates.
  2. Massive Project Investment Funding – The International Energy Agency estimates that over one billion dollars per day will be invested in solar energy in 2023.
  3. Consistent Long-Term Incentives – The Inflation Reduction Act is a game-changer, supercharging renewables with $1.2 trillion in tax credits for 10 years of market support.
  4. Robust Customer Demand – Wood Mackenzie expects the U.S. solar industry to nearly triple in size over the next five years.

Correlate’s team of multi-decade experts who have worked with renowned global brands are positioning the company to make the most of this opportunity while consolidating a fragmented industry. Collectively, the team has developed, financed and deployed over $2 billion in clean energy projects to date.

Three-Pronged Strategy

Correlate is leveraging a three-pronged strategy aimed at driving shareholder value:

  1. Sell – Correlate seeks to finance, develop and profitably sell localized clean energy solutions and microgrids to industrial, commercial and residential customers.
  2. Retain – Correlate plans to retain ownership of some of these energy systems and thereby realize ongoing, reliable cash flow.
  3. Acquire – Correlate seeks to acquire proven renewable energy companies in order to exponentially grow earnings per share for investors.

This strategy is enhanced by current investment trends. Clean energy earnings are being sought after by investors. In Q4 2022, the median EBITDA multiple for green energy companies was 12.3x, according to Finerva.

Market Outlook

Over the next decade and beyond, renewable energy growth is expected to come primarily via decentralized systems like those offered by Correlate.
The Inflation Reduction Act enacted in late August 2022 is likewise expected to drive growth for the company by providing new tax incentives that reduce costs for clients and/or elevate returns to investors.

Commercial buildings consume more than 35% of the generated electricity in the U.S. and are underperforming in energy efficiency at every level. These buildings waste energy, emit too much carbon and are too costly for owners and occupants, but retrofits are not happening at the rate or scale needed.

In today’s real estate market, portfolio property owners own most commercial buildings, yet most building efficiency work is focused on single buildings, thereby missing the distinct needs of this owner class which are very different from traditional owner-occupiers. The diverse nature of commercial buildings, combined with technology and performance uncertainty, make simple energy optimization initiatives – which could greatly reduce energy use and improve building value – financially unattractive, resulting in slow adoption rates. CIPI’s financial instruments and software breakdown this issue, known as the ‘split incentive’, unlocking the majority of the addressable market.

A key portion of Correlate’s strategy relates to consolidation of what has been a fragmented industry. By uncovering opportunities to improve efficiencies through strategic M&A activities, the company intends to enhance profitability throughout its operations.

Management Team

Todd Michaels is President and CEO of CIPI and founder of Correlate. He formerly served as Vice President for Innovation at SunEdison and Senior Director Distributed Solar at NRG Energy. He founded Correlate in 2015 and has 16 years of experience in the energy industry. He graduated from Indiana University with a B.S. in Computer Information Systems.

Channing Chen is CFO at CIPI and Correlate Inc. and brings over 16 years of experience in the solar industry as a developer, financier, and business unit leader. He has held executive management roles at Solar Power Partners (acquired by NRG Energy), where he was a founding employee, SunEdison, and NRG Energy (NYSE: NRG). Most recently, Mr. Chen was founder and Managing Partner at Breakaway Energy Partners LLC – a distributed energy financing and market-making platform. To date, Mr. Chen and his teams have raised over $1.5 billion in financing across residential, commercial, and utility scale solar and energy storage projects representing over 400 MWs. He holds a B.A. in Environmental Chemistry from the University of California at San Diego and an MBA from the University of Southern California. He is also an advisor and early-stage investor to several startup companies in the renewable energy space.

Dave Bailey is Chief Revenue Officer of Correlate Inc. With over 15 years of executive sales, supply chain management, and energy efficiency experience, he is responsible for ensuring the success of the National Commercial Sales Unit across multiple regional project teams. Mr. Bailey created and launched the Transformation Services team while at Wesco for its multibillion-dollar Distributed Energy Resource division, formerly Westinghouse. His focus was on IoT-enabled efficiency and plant floor automation-based services. Before that, he spent several years in Global Account Sales Management, with GE Supply as a Program Manager, and is a Commercial Leadership Program graduate. Mr. Bailey received his B.S. in Mechanical Engineering from the University of Kentucky.

Jed Freedlander is the company’s Chief Development Officer. He has a background in infrastructure development and investment and a strong legal, commercial and finance acumen. Mr. Freedlander has a proven track record in leading complex public-private partnership (P3) and energy transactions and is instrumental in driving Correlate’s strategic development initiatives.

Roger Baum is Executive VP Operations at Correlate. With over 20 years of experience at Core Construction, he brings to the company a wealth of knowledge and a strong track record in delivering successful commercial construction projects.

Jason Loyet is Director of Solar Energy for Correlate Inc. He is a cleantech executive with over 20 years of experience leading high growth solar energy and software start-ups. Mr. Loyet is a U.S. Department of Energy SunShot Catalyst award winner for his work building the Solar Site Design technology platform. Before joining the solar energy industry in 2005, he founded and sold two software companies in the streaming media (GlobalStreams) and newspaper publishing (MyCapture) industries. Mr. Loyet currently serves as a Member of the Board of Directors for the Tennessee Solar Energy Industry Association (TenneSEIA).

Correlate Energy Corp. (OTCQB: CIPI), closed Wednesday's trading session at $1.246, off by 0.0801925%, on 100 volume. The average volume for the last 3 months is 1,414 and the stock's 52-week low/high is $0.50/$2.35.

Recent News

Clene Inc. (NASDAQ: CLNN)

The QualityStocks Daily Newsletter would like to spotlight Clene Inc. (NASDAQ: CLNN).

Clene (NASDAQ: CLNN) and its wholly owned subsidiary Clene Nanomedicine Inc., are reporting on first-quarter 2024 financial results and operating highlights for its CNM-Au8 clinical program for amyotrophic lateral sclerosis ("ALS") and multiple sclerosis ("MS"). Clene Nanomedicine is a late clinical-stage biopharmaceutical company focused on revolutionizing the treatment of neurodegenerative diseases. Highlights of the report include the news that data from the long-term extension of Clene's phase 2 VISIONARY-MS clinical trial of CNM-Au8® exhibits significant evidence of repair and remyelination across multiple paraclinical endpoints; the publication of an article in the "ACS Pharmacology & Translational Science," a journal that publishes impactful research showing translational relevance across a broad spectrum of biological sciences; the receipt of a $7.3 million subaward from the National Institute of Health ("NIH") grant for its ALS Expanded Access Program; and ending Q1 2024 with cash, cash equivalents and marketable securities of $27.9 million. "In the first quarter our team worked diligently to advance our FDA discussions in ALS while continuing to generate more data supporting the neurological benefits and mechanism of action of CNM-Au8," said Clene president and CEO Rob Etherington in the press release. "We look forward to a productive and collaborative FDA meeting by mid-2024 and laying the groundwork toward filing of a New Drug Application in the second half of the year. Additionally, we are very pleased to see the recent data from our long-term extension of the VISIONARY-MS study. These data represent significant evidence of repair and remyelination across multiple paraclinical endpoints and provide us with greater support for the continued clinical evaluation of CNM-Au8 for this important indication."

To view the full press release, visit https://ibn.fm/rARH7

Clene Inc. (NASDAQ: CLNN) is a late clinical-stage biopharmaceutical company focused on improving mitochondrial health and protecting neuronal function to treat neurodegenerative diseases, including amyotrophic lateral sclerosis (ALS), Parkinson’s disease, and multiple sclerosis (MS).

Its lead drug candidate is CNM-Au8®, an oral suspension developed to restore neuronal health and function by increasing energy production and utilization by driving critical cellular energy producing reactions that enable neuroprotection and remyelination to increase neuronal and glial resilience to disease-relevant stressors. CNM-Au8 is being studied in various clinical trials, including the Harvard/MGH Healey ALS Platform clinical trial for patients with ALS; RESCUE-ALS, a completed proof-of-concept clinical trial in patients with early symptomatic ALS; the REPAIR trials, completed target engagement clinical trials showing brain energy metabolite change with CNM-Au8; and a completed MS clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing MS. The company also has a nanotherapeutic platform of drug discovery.

CNM-Au8

CNM-Au8, Clene’s lead asset, is a highly concentrated aqueous suspension of catalytically active, clean-surfaced, faceted gold nanocrystals. Multiple pathogenic insults contribute to neuronal death. Mitochondrial dysfunction and NAD+ decline is a common final pathway in neurodegeneration, with NAD+ as a critical determinant of cell survival and function. CNM-Au8’s catalytic mechanisms target the energetic deficits, oxidative stress and accumulation of misfolded proteins that are common to many neurodegenerative diseases.

The unique catalytic mechanism of action of CNM-Au8 is hypothesized to act as a neuroprotective and remyelinating therapy in neurodegenerative disease states in order to: (1) drive, support and maintain beneficial metabolic and energetic cellular reactions within diseased, stressed and/or damaged cells, (2) directly catalyze the reduction of harmful, reactive oxygen species (“ROS”) and (3) promote protein homeostasis via activation of the heat shock factor-1 pathway, recognized to dampen the cytotoxicity caused by misfolded and denatured proteins, which are known to occur ubiquitously in neurodegenerative diseases.

CNM-Au8 is used in combination with other agents, has no known drug-drug interactions, and is designed to improve function and survival. The clinical effects of both function and survival were seen in its clinical ALS trials, as earlier announced.

More than 500 estimated years of collective exposure across ALS, MS, and Parkinson’s disease participants in CNM-Au8 clinical trials and Expanded Access Protocol (compassionate use) programs have been recorded without any observed safety signals.

CNM-Au8 is a federally registered trademark of Clene Inc. Clene, based in Salt Lake City, Utah, with R&D and manufacturing operations in Maryland, began in 2013.

Market Opportunity

ALS is the most prevalent adult-onset progressive motor neuron disease, affecting approximately 30,000 people in the U.S. and an estimated 500,000 people worldwide, with a life expectancy of typically three to five years. Clene estimates that global ALS treatment sales will be greater than $1 billion annually within the coming few years. Additional treatments affecting daily function and survival remain the market need.

Additionally, there are more than 2 million MS patients globally, and Clene estimates the market size to be worth more than $23 billion annually. While the MS community has been successful at limiting relapses, non-relapsing MS patients continue to clinically deteriorate even while receiving effective immunomodulatory disease-modifying therapies (“DMTs”). A critical unmet medical need remains for therapeutic interventions that protect neuronal function and myelin health independent of immunomodulation to address progression independent of relapse activity.

Management Team

Robert Etherington is President, Director and CEO of Clene. He has more than 30 years of sales, marketing and leadership experience in the pharmaceutical industry. Prior to joining Clene, he worked at Actelion Pharmaceuticals, the largest biopharma company in the European Union prior to its acquisition by Johnson & Johnson in 2017, where he led that company’s U.S. commercial operations. He began his pharmaceutical sales and marketing career at Parke-Davis, a division of Pfizer, where he rose to the position of Team Leader overseeing the drug Lipitor.

Mark Mortenson is Chief Science Officer at Clene. He is co-inventor of the technology platform developed to produce the company’s therapeutics. He is the inventor or co-inventor on 32 other U.S. patents and hundreds of corresponding international patents. He is a former chief patent counsel responsible for 5,500 U.S. and international patents and patent applications. He holds bachelor’s degrees in physics and ceramic engineering from Alfred University, a master’s degree in materials science from Penn State University and a J.D. from George Washington University.

Benjamin Greenberg, M.D., MHS, FAAN, is Head of Medical at Clene. He is an internationally recognized expert in disorders of the central nervous system. He is currently professor of neurology and Vice Chair of Clinical and Translational Research in the department of Neurology at University of Texas Southwestern Medical Center in Dallas. He holds a bachelor’s degree from Johns Hopkins, a master’s degree in molecular microbiology and immunology from the Johns Hopkins School of Public Health and graduated from Baylor College of Medicine. He served residency in neurology at The Johns Hopkins Hospital.

Morgan R. Brown is CFO at Clene. He has more than 30 years of finance and accounting experience, with 23 years at biotech, pharmaceutical and medical device companies. He has served in similar roles at Lipocine Inc., Innovus Pharmaceuticals, World Heart Corp., Lifetree Clinical Research and NPS Pharmaceuticals Inc. He previously worked at accounting firm KPMG. He is a CPA with a bachelor’s degree in accounting from Utah State University and an M.S. in business administration from the University of Utah.

Clene Inc. (NASDAQ: CLNN), closed Wednesday's trading session at $0.3899, off by 0.3832397%, on 454,635 volume. The average volume for the last 3 months is 955,414 and the stock's 52-week low/high is $0.25/$1.09.

Recent News

SOBRsafe Inc. (NASDAQ: SOBR)

The QualityStocks Daily Newsletter would like to spotlightFathom SOBRsafe Inc. (NASDAQ: SOBR).

SOBRsafe, providing the latest in transdermal alcohol detection solutions, has signed another new customer, one that provides full continuum care, from inpatient detox and residential treatment to outpatient services, and has now installed SOBRcheck(TM) in each of its four facilities to enable point-of-care screening

The customer is also evaluating SOBRsafe's wearable band, SOBRsure(TM), for continuous monitoring in an outpatient application

The new Florida client is one of sixteen new accounts that SOBRsafe secured during the first quarter of 2024

The global alcohol sensor market was valued at $2.3 billion in 2022 and is expected to grow at a CAGR of 13.7%, resulting in a value of $6.3 billion by 2030

SOBRsafe (NASDAQ: SOBR), a provider of next-generation transdermal alcohol detection solutions, recently announced that they have signed a hardware/software agreement with a four-facility behavioral health provider based in Florida. (https://ibn.fm/7cxba).

SOBRsafe Inc. (NASDAQ: SOBR) is a provider of a game-changing transdermal (touch-based) alcohol detection technology that can improve workplace safety and provides advanced screening and monitoring solutions for the behavioral health industry.

Alcohol misuse is the fourth leading cause of preventable death in the U.S., and the seventh worldwide. Nearly half of all industrial accidents with injuries are alcohol-related, and 1-in-10 U.S. commercial drivers tests positive for alcohol – the highest rate in the world. Despite these statistics, prevention and monitoring solutions have not kept pace with this epidemic. Legacy detection technologies are invasive and inefficient, unhygienic and unconnected. SOBRsafe believes there is a better way.

The company has developed a patent-pending alcohol detection device called SOBRcheck™ for use in detecting alcohol in humans, with just the touch of a finger. SOBRsafe’s next-generation transdermal technology detects and instantaneously reports the presence of alcohol as emitted through a user’s skin. No breath, blood or urine sample is required. SOBRsafe believes its technology is a superior, hygienic alternative to traditional breathalyzers for frontline, preventative applications.

With a powerful backend data platform, SOBRsafe provides humane, passive and connected alcohol detection for the behavioral health, transportation, oil and gas, judicial and consumer markets.

A preventative solution in historically reactive industries, SOBRsafe technology is being deployed for commercial fleets, workplaces, alcohol rehabilitation, probation management and teen drivers. This monitoring technology helps prevent intoxicated workers from taking the factory floor or drivers from receiving the keys to a truck, bus or family car. An offender is immediately flagged, and an administrator is empowered to take the appropriate corrective actions.

SOBRsafe technology is commercially available for access control (SOBRcheck), wearable use (SOBRsure™) and licensing or white labeling.

The company is headquartered in the Denver (CO) Technology Center.

Products

The SOBRsafe technology is integrated within the company’s robust and scalable data platform, producing statistical and measurable user and business data.

SOBRsafe™

With a mission is to save lives, increase productivity, create significant economic benefits and positively impact behavior, SOBRsafe developed the scalable, patent-pending SOBRsafe™ platform for non-invasive alcohol detection, real-time reporting and historical data aggregation.

SOBRsafe is a solution that has broad applications in behavioral health, fleet and facility safety, youth drivers and judicial markets.

SOBRcheck™

SOBRcheck is the company’s stationary identification and alcohol monitoring product, providing a quick, specific-point-in-time test for the presence of alcohol. In hygienic, real-time fashion, SOBRcheck verifies user identity and determines the absence or presence of alcohol.

SOBRcheck provides an administrator immediate results – delivered securely – to aid in the efficient management of an existing substance abuse policy.

SOBRsure™

SOBRsure is the company’s transdermal, alcohol-detecting wearable. SOBRsure provides continuous, mobile alcohol monitoring. The band’s advanced alcohol safety technology discreetly detects and instantaneously reports the presence of alcohol in the body. Additionally, SOBRsure provides app-based alcohol detection alerts, pinpoint location tracking and band-removal notifications.

The SOBRcheck and SOBRsure revenue models consist of two components: (1) a hardware device purchase and (2) a recurring monthly SaaS subscription fee.

Design, manufacturing, quality testing and distribution for all SOBRsafe devices takes place in the U.S.

 

Market Opportunity

A report from Data Bridge Market Research, an international market research and consulting firm, estimated the global alcohol sensor market at $2.3 billion in 2022. The market is forecast to reach a value of $6.3 billion by 2030, recording a CAGR of 13.7% over the forecast period.

Market growth drivers, as cited by the report, include rising alcohol consumption rates, more stringent laws pertaining to alcohol consumption and new, more effective technologies that facilitate detection and enforcement.

Greater awareness of alcohol consumption as a potential threat to public and workplace safety has led to increased emphasis on preventing operation of motor vehicles and machinery by those under the influence of alcohol and promoting responsible alcohol consumption, as the report details.

Management Team

David Gandini is Chairman and CEO of SOBRsafe. He most recently served as president of IPS Denver, a bank card personalization company. Prior to that, Dave was the COO at First World Communications, a U.S. internet and data center provider, and participated in its successful IPO. He previously founded Pace Network Services and facilitated a successful exit to ICG Communications. Dave also co-founded Detroit-based Digital Signal in the fiber optic long haul market sector, where he executed a successful exit to SP Telecom.

Chris Whitaker, CPA, is CFO of SOBRsafe. Previously, Chris had served as the Company’s Vice President of Finance and Accounting. He has held various executive finance positions with large public multi-national corporations and small entrepreneurial companies throughout a progressive 30-year career that began with KPMG. Chris was formerly President – Americas and Vice President of Finance and Administration for public, multinational corporation Elixinol. He also served as the Managing Director of AEGIS Financial Consulting, leading a team of consultants in providing fractional CFO and financial consulting services to a wide variety of businesses in the public and private sectors.

Scott Bennett is EVP, Business Operations at SOBRsafe. He has more than 20 years of experience as a senior executive in technology-driven enterprises. Prior to joining SOBRsafe, he co-founded cybersecurity firm GBprotect and served as its COO until its successful sale to Nuspire. He previously served as Chief Technical Officer/Chief Information Security Officer of fintech businesses Catalyst Card Company and Integrated Printing Solutions.

SOBRsafe Inc. (NASDAQ: SOBR), closed Wednesday's trading session at $0.2305, off by 4.3568%, on 85,220 volume. The average volume for the last 3 months is 110,850 and the stock's 52-week low/high is $0.2004/$2.20.

Recent News

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.

The QualityStocks Numbers Report

By The Numbers Chart

Top Performers


QualityStocksTwits

QualityStocksTwits is your stock tracking service portal to Twitter's universe of stock picks, commentary and research.

Visit Portal


The QualityStocks Sponsored News


The QualityStocks DailyNetwork Sponsors

CannabisNewsWireCanadianCannabisNewsWireCNW420CannabisNewsWatchCBDWireCryptoCurrencyWireGot Stocks?Got Stock Tips?Green On The StreetHempWireNewsInvestorOutreachCenterMissionIRMissionIR MediaMissionPR MissionSMRNetworkNewsWireNetworkNewsWatchNetworkWireQualityStocks MediaQualityStocksQualityStocks TwitsSeriousTradersSmallCapRelationsSocial Media RelationsSmallCapSocietyTiny GemsTip.usTraderPower

ActionStockPicksAgressive StocksBetting On Wall StreetGreen Car StocksGreen Energy StocksHomeRunStocksInvestorBrandWireQStocksStock BeatsStockTipsStocks To Buy NowTerrificStocks

About The QualityStocks Daily

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?
We Want To bring our subscribers the top movers in an unbiased setting.

"Homework Eliminates Mistakes"
Please never invest in a company anyone profiles unless you do the proper research and due diligence.

QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.

Please consult the QualityStocks Market Basics Section on our site.